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ABSTRACT 
 
In Malawi, sputum smear microscopy (Ziehl-Neelsen) is a major diagnostic technique for 
pulmonary tuberculosis (TB). Though relatively rapid, it tends to be poorly sensitive 
since it requires a large number of organisms to be present in the specimen before they 
can be detected. Two approaches that improve sensitivity of direct smear microscopy are 
sputum liquefaction with chemicals such as sodium hypochlorite (household bleach) and 
subsequent concentration with gravity (natural) sedimentation and centrifugation. This 
study estimated the costs and cost-effectiveness of these techniques in processing sputum 
for detecting new cases of pulmonary tuberculosis in Malawi. 
 
Bleach natural sedimentation and bleach centrifugation methods were compared with 
direct smear microscopy. Cost and effectiveness data were collected from a randomized 
controlled trial from one major TB health facility. Effectiveness was determined by 
number of smear positive TB cases detected by each method. Cost-effectiveness was 
estimated from a provider’s perspective in terms of cost per TB cases diagnosed and cost 
per smear positive TB case detected. 
 
Cost per positive TB case detected was least in natural (gravity) sedimentation (US 
$9.35), compared to centrifugation (US $11.48) and direct smear microscopy (US 
$15.93). The study findings indicate that natural sedimentation can significantly reduce 
cost of sputum processing. There is a strong economic case supporting the use of natural 
sedimentation for diagnosing tuberculosis in Malawi. In addition, bleach digests sputum 
making it less infectious and easy to work with thereby increasing the safety of 
specimens to clinicians. Therefore, introducing natural sedimentation technique would 
not only reduce costs but also improve safety to health workers. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Background 
 
Tuberculosis (TB) remains a major global public health challenge. The World Health 
Organization (WHO) and the World Bank (WB) estimate that globally, 8.8 million cases 
are detected of which approximately 1.6 million people die annually (World Health 
Organisation 2007a). The Sub-Saharan Africa is among the worst affected regions with 
an incident rate of 350 per 100,000 (World Health Organization 2007b). According to the 
WHO Global TB 2008 Report, there were an estimated 51,172 new cases of TB in 
Malawi of which 33000 are also HIV positive, but the Malawi’s National TB Control 
Program (NTCP) estimates are around half that (Banda 2009). This indicates that TB case 
detection in Malawi is about 50%.  
 
Tuberculosis is among the three major killer diseases, behind Malaria and Human 
Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS). The 
disease burden has been exacerbated by TB-HIV co-infection, where HIV positive 
individuals are prone to developing TB due to weakened immune systems of HIV 
infected persons. This leads to increased number of tuberculosis cases per year. Worse 
still, the majority of people with TB or TB/HIV co-infection are in the economic 
productive age group.  This implies that, productivity within this age group decreases and 
consequently, the economic growth of the country also decreases (Kim et al. 2009). 
 
Direct smear microscopy has been a major tool for diagnosing tuberculosis. However, the 
low sensitivity, which has also been worsened by increasing TB/HIV co-infection, has 
affected the number of TB cases that can be promptly diagnosed (Bruchfeld et al. 2000, 
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Lawson et al. 2007). Tuberculosis is not only harder to diagnose in HIV positive patients, 
but it also tends to progress faster (AVERT 2009). A study by Hargreaves et al. (2001), 
done in an areas of high HIV seroprevalence  in Malawi, noted that 22% of the smear 
negative TB patients were actually confirmed to be smear positive after some weeks of 
re-examination. The identification of patients who have positive sputum smears is 
crucial, since these patients are the most infectious especially to close contacts. 
 
In the 1980’s, TB cases were much lower in Malawi, with public health facilities having 
to treat about 5000 patients annually (Banda 2009). The rising number of TB cases has 
put considerable strain on the public health system (Wandwalo et al. 2005, Harries et al. 
1999). A study conducted by Harries et al. (1999) in Malawi, also indicated that, the high 
incidence of TB has greatly increased risk of infection amongst all categories of health 
workers, especially clinical officers (Harries et al. 1999). With per capita health 
expenditure of US $19 (The Global Fund 2008) and few health workers, TB epidemic 
significantly affects the Malawi’s health system performance. Consequently, identifying 
new methods that maintain or improve sensitivity in detecting sputum smear positive TB 
cases; reducing the risk of transmission among health workers, and at the same time 
reducing demand on health resources and lowering cost of diagnosis is pertinent. Two 
promising approaches are sputum liquefaction with chemicals such as sodium 
hypochlorite (household bleach) and subsequent concentration with gravity (natural) 
sedimentation and centrifugation.  Bleach disinfects sputum specimens rendering them 
less infectious and thus reducing risk of transmission amongst health workers.  In 
addition, household bleach is universally accessible at an affordable cost. 
 
1.2 Country Setting 
 
Malawi is located in central Africa covering an area of 118,480 sq km (45,745 sq miles), 
of which 24,400 sq km (9,420 sq miles) consists of water, predominantly Lake Malawi. 
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The country borders Tanzania, Zambia and Mozambique to the north and west, south, 
south-west and south-east respectively. 
The 2008 national population census estimated the country’s population at 13 million 
people, with 49% of the population being males and 51% being females (National 
Statistical Office 2008). The total annual population growth rate is estimated at 2.8%. 
Birth rate is estimated at 41.79 births/1000 and death rate at 17.89/1000 population. 
Infant mortality rate is at 90.55 deaths/1000 live births. Life expectancy at birth is 43 
years. 
 
The Government through a wide network of health centres and hospitals principally 
provides 60% of health care. The second major provider is a group of mission hospitals 
commonly known as Christian Health Association of Malawi (CHAM) hospitals (40%). 
There is also a visible presence of private health facilities mainly within the urban areas 
of the country. Traditional practitioners such as birth attendants also play a role in 
providing health care. 
 
The Malawian economy, with gross domestic product (GDP) of US $850 in 2008, has 
been heavily reliant on agriculture, with tobacco being the main cash crop and major 
source of foreign earnings. In addition, sugar, tea and coffee provide additional sources of 
foreign exchange. Recently, the country has ventured into uranium mining in the northern 
part of the country. This is expected to be the major export commodity that could replace 
tobacco. 
 
1.3 Rationale of the study 
 
In Malawi, sputum smear microscopy (Ziehl-Neelsen) is a major diagnostic technique for 
pulmonary tuberculosis. Though relatively rapid, it tends to be poorly sensitive since it 
requires a large number of organisms (>105 orgs/ml) to be present in the specimen before 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
  
 
4 
they can be detected (Ramsay et al. 2006). A more definite method of detecting 
tuberculosis is through culture where mycobacterium tuberculosis (MTB) are grown. 
However, this may take up to 10 weeks before results are available, as such though 
definitive, it is not ideal for patient management and control of transmission of MTB. 
Attempts have been made to improve the sensitivity of tools and different techniques 
used to detect especially sputum smear positive cases. Factors that improve sensitivity of 
sputum smear examination include homogenization of sputum with Sodium Hypochlorite 
(NaOCl); that is household bleach, followed by concentration either by sedimentation or 
centrifugation (Aderaye et al. 2007). Natural sedimentation allows particles to settle 
down separated by size and density allowing massive components of a liquid to settle at 
the bottom. Similarly, centrifugation is a method of separating molecules by size or 
density using centrifugal forces by a spinning rotor. More massive components of the 
liquid are pressed toward the outside of the centrifuge with more force, so they settle to 
the bottom of the test tube.
 
 While centrifugation requires a centrifuge and electricity, 
sedimentation can be done locally where such facilities are not present. Both methods 
increase concentration of the molecules in the specimen, which then improves the 
diagnostic yield of the specimen. When more patients are detected in the early stages and 
put on treatment early, transmission rate has been found to decrease significantly. 
Late detection of TB imposes a greater challenge on poor outcomes in terms of death rate 
which is high particularly for HIV infected patients (Mort 2004). Thus, it has become 
imperative that more cases are detected at a least possible cost, when TB is in its early 
stages so that patients can be promptly placed on treatment to curtail further transmission 
of tuberculosis germs. Such an intervention requires improved TB diagnostic techniques 
for those cases that present at the health facilities over and above encouraging patients to 
attend health facilities if and when they experience TB symptoms. 
 
In addition, the global report for 2009 indicates that, case detection rate in Malawi has 
been stagnant at around 40% with treatment success rate at 70% for a period of over 
5years (USAID 2009). The low rate of case detection is also a concern for several 
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reasons. Some of these include the delay it imposes on attainment of the TB related 
Millennium Development Goals (MDGs) which targets reducing TB prevalence by half 
by 2015 compared with 1990 (World Health Organisation 2007b), diagnosing 70% of 
new smear positive cases and curing 85% of these cases by 2015 (Baltussen et al. 2005). 
At the current rate of progress, achieving these targets will be an immense challenge. An 
important question is whether the correct mix of intervention is being used and what 
strategies should be used to achieve global set targets (Baltussen et al.2005).  Assessment 
of cost and cost effectiveness of alternative options can help with such decisions. When 
such strategies are identified and implemented, it would contribute to attainment of 
millennium development goals, thus improving population health. 
 
The World Health Organisation (2005) recognizes that some countries, especially those 
with high HIV prevalence, have already implemented concentration techniques for 
sputum examination while others are still in the process of implementing them. Taking 
into account that TB is highly prevalent in poor countries where resources are very 
scarce, it is crucial that countries determine whether these methods can offer the 
maximum benefits at the least possible cost before prematurely adopting these methods. 
To determine which methods will give us maximum benefits, it is essential that economic 
evaluation be used and as an aid to guide policy makers in decision-making process 
(Drummond et al. 2005). 
 
There seems to be an information gap concerning the cost-effectiveness of smear 
microscopy, natural sedimentation and centrifugation techniques. Lack of information 
should drive us to expand our research efforts (Ramsay et al. 2006). This study seeks to 
fill this information gap. To the best of my knowledge, globally, very few published 
studies have looked at cost-effectiveness of these techniques in analyzing sputum for 
Tuberculosis diagnosis. Thus, it has become pertinent to estimate cost effectiveness of 
these techniques with a view to guide policy in prioritization of resource use. 
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6 
1.4 Aim and objectives of the study 
 
1.4.1 Aim 
 
To investigate the cost-effectiveness of direct smear microscopy, bleach natural 
sedimentation and bleach centrifugation methods in processing sputum for detecting new 
cases of pulmonary tuberculosis in Malawi. 
 
1.4.2 Specific objectives 
 
(1) To estimate the provider costs of each of the three methods for analyzing sputum. 
(2) To determine the effectiveness of each of the methods in processing sputum. 
(3) To estimate and compare the cost effectiveness of these three different approaches for 
analyzing sputum. 
(4) To make policy recommendations on techniques of analyzing sputum for detecting 
new cases of pulmonary tuberculosis. 
 
1.5 Organization of the thesis 
 
The rest of the thesis has been organized as follows. The second chapter is a literature 
review. It looks at other economic evaluation studies paying particular attention to 
effectiveness of the methods used, how they measured effectiveness and calculation of a 
cost effectiveness ratio. This chapter also describes scope of costs included in the studies. 
Finally the chapter outlines the conceptual framework, which helps to understand how 
economic evaluation will be conducted in this study. 
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7 
Chapter three presents the methodology of the study. The chapter also outlines the types 
of cost data collected and measures of effectiveness used in the study. 
 
Chapter four presents the study findings in terms of costs and cost-effectiveness. The 
chapter also presents the measure of effectiveness which is the number of smear positive 
tuberculosis patients detected. The results of a number of sensitivity analyses then are 
given. 
 
Chapter five discusses results of the study in relation to provider’s costs, cost 
effectiveness and resource use. Limitations of the study are also highlighted. 
 
Finally, chapter six gives the conclusions of the study and outlines the policy 
recommendations emanating from the study findings. 
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CHAPTER 2 
  
LITERATURE REVIEW 
 
2.1 Introduction 
A number of studies have been conducted on the cost-effectiveness analysis of 
Tuberculosis. Some of these studies have focused on diagnosis, whilst others have 
focussed on treatment and case management. This chapter reviews some of these studies 
with particular emphasis on studies that have looked at diagnosis. Firstly, studies that 
have focussed solely on the effectiveness of different methods of TB diagnosis are 
discussed. Secondly, studies that have looked at cost-effectiveness analysis of TB 
diagnosis are reviewed, with critical evaluation of the methodologies used. These 
methodologies include perspectives of the economic evaluation, data collected, scope of 
cost data, effectiveness measures, measures of cost effectiveness analyses and how 
sensitivity analysis were performed. The last section of this literature review focuses 
mainly on resource allocation requirements. The aim of this latter section is to explain 
how equity concerns need to be considered when using cost-effectiveness analyses to 
allocate resources for health interventions. 
 
2.2 Effectiveness analysis 
 
Direct sputum smear microscopy is the basis of TB diagnosis in most low and middle-
income countries (Steingart et al. 2006). This method is rapid, inexpensive, and highly 
specific and is also capable of identifying the most infectious cases of TB (Steingart et al. 
2006). However, problems with its limited sensitivity have prompted investigation of 
alternative techniques that are more sensitive in detecting the TB bacilli. Some of these 
methods include Polymerase chain reactions (PCR), fluorescence microscopy (FM), 
bleach sedimentation (BS) and bleach centrifugation (BC). With respect to PCR, several 
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studies have found that, PCR is a more sensitive and faster method of diagnosing TB, 
compared to direct smear microscopy (Haldar et al. 2007). However, these advantages 
 
are 
partially offset by economic factors as well as technical factors (test is complicated to run 
in a laboratory), making this method less suitable for use in resource-poor settings. 
Regarding fluorescence microscopy (FM), a systematic review by Steingart et al. (2006) 
reported that fluorescence microscopy of auramine-stained smears gave a similar 
specificity and on average a 10% higher sensitivity than Ziehl-Neelsen staining in 18 
studies analysed.  Higher sensitivity was observed in 16 of these studies (Steingart et al. 
2006). In addition, fluorescence microscopy done on one or two specimens was more 
cost-effective than the Ziehl-Neelsen method used on three sputum specimens. 
Furthermore, FM has been shown to have an added advantage of reducing the time that is 
required for examination of smears, with about 15 times as many fields of view being 
scanned by FM as by conventional microscopy in the same period (Getahun et al. 2007).  
These results indicate that FM could have a major role to play in TB diagnosis in the near 
future.  However, certain factors still threaten the implementation of FM in resource 
constrained settings.  These factors include the high cost of fluorescence bulbs, their short 
lifetime (typically 200–300 hours) and also the need for expensive power supplies.  
Irregular power supplies in resource-poor settings are also likely to have an impact on the 
FM bulb life (WHO 2005). 
 
Despite the general feeling that FM cannot be implemented in resources constrained 
areas, a recent study in Kenya challenges that fluorescence microscopy (FM) used on one 
or two specimens for the detection of tuberculosis (TB) was more cost-effective than a 
Ziehl-Neelsen (ZN) approach, (Kivihya-Ndugga et al. 2003).  The study suggests that the 
modern method can be implemented at a lower cost than the conventional direct smear 
microscopy.  Particularly, with high numbers of suspects and high prevalence of HIV, the 
authors recommended the use of FM on two specimens. Furthermore, the method has an 
advantage that it shortens diagnostic process thus making it more efficient in obtaining 
test results and may reduce patient costs such as opportunity costs of waiting time. 
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Sputum liquefaction with subsequent concentration by centrifugation and gravity 
(natural) sedimentation are the other 2 methods that are being popularly investigated with 
regard to the role they could play in optimizing smear microscopy.  Liquefaction has 
been performed using solvents such as sodium hydroxide, sodium hypochlorite 
(household bleach), N-acetyl-L-cysteine-sodium hydroxide solution, and ammonium 
sulphate (Getahun 2007). According to a WHO expert consultation meeting that was held 
in 2005, there is moderate evidence supporting the use of centrifugation with various 
chemical methods. The 14 studies that have investigated the impact of centrifugation with 
a chemical (using culture as the reference standard) indicated a mean increase in 
sensitivity of smear microscopy of about 18%.  Out of these 14 studies, 13 showed an 
increase in sensitivity and one study showed a decrease.  The evidence base for the use of 
bleach with centrifugation is also moderate.  The studies that were reviewed by Steingart 
et al. (2006) showed that, there was a mean increase of about 15% in sensitivity, with 
sensitivity ranging from about +1% to about +38%. Despite this, all the studies showed 
that sensitivity for processed smears was higher than for direct smears.  More recently 
Ängeby et al. (2000) and Merid et al. (2009) have also reported similar results. 
 
Based on the studies reviewed above, it can be concluded that the available evidence 
suggests that processing sputum by use of centrifugation and various chemicals, 
including bleach, increases the sensitivity of microscopy compared with the direct smear 
method. However, the evidence base supporting the feasibility of implementing bleach 
centrifugation in low-income settings is still low.  Concerns that have been raised with 
the use of these methods in resource poor settings include: 
1. feasibility of centrifugation in settings with irregular power supply; 
2. limited human resources to operate the machinery 
3. limited financial resources to meet the recurrent cost of centrifuges and the cost of 
power required to run the machines 
4. inadequate training capacity 
5. potential biohazard posed by centrifugation of liquefied infectious sputum 
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Thus, studies that are conducted in such peripheral settings are imperative so as to 
determine whether this method has a role to play in such settings. 
 
As highlighted earlier, the other sputum processing technique that is currently being 
explored as a means of optimizing smear microscopy is liquefaction of sputum with 
subsequent concentration using natural sedimentation.  However, the existing evidence 
base for processing sputum using natural sedimentation is still weak. A total of 8 studies 
(four using overnight sedimentation and four using short sedimentation times of 30–
45min) investigated the effect of sedimentation with a variety of chemical agents, usually 
either bleach or ammonium sulphate (Steingart et al. 2007).  These studies used culture as 
the reference standard.  The findings of these studies indicated that, the mean increase in 
sensitivity was 23% (median 28%; range 2–34%) in studies using overnight long 
sedimentation, whilst the studies which used short sedimentation times reported average 
increases that were more modest at 9% (median 1%; range 0–36%). 
 
The four large studies that investigated natural sedimentation with bleach (using culture 
as standard), found out that this technique increased the sensitivity of smear by about 
33%. However, this result was only specific to the 1 study that had used long 
sedimentation times.  The other 3 studies, that used short sedimentation times reported no 
or minimal increases in sensitivity (0%, 0%, and 1%).  A more recent study by  Merid et 
al. (2009) which investigated bleach sedimentation using shorter and longer 
sedimentation times found out that sensitivity was higher with BS (regardless of 
sedimentation times) than with direct smear microscopy. Similar to the findings of the 
other studies, overnight sedimentation increased the sensitivity of the sputum smear 
compared to short sedimentation time.  However, this increase in sensitivity was lower 
than that reported in the 4 studies, possibly because of the differences in protocols 
followed. 
 
The problems that can be identified in these studies is lack of standardization of 
procedures used in the studies.  The studies differ in terms of the concentration of bleach 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
  
 
12 
or volume of distilled water used. For example, a study by Miorner et al. (1996) used 5% 
of sodium hypochlorite; 8ml of distilled water was added whilst a study by Gebre et al. 
(1995) used 4.4% of sodium hypochlorite, 6ml of distilled water. Such differences in 
concentration levels have been found to affect smear results. A higher concentration is 
associated with poor smear outcomes. A study done in Kenya with 232 smear specimen, 
after adding a step where 3.5% (sodium hypochlorite) was added to specimen and 
allowed to sediment overnight, Zielhl-Neelsen staining achieved a sensitivity 
approaching that of culture (27.1% were positive versus 29.3% that were culture positive) 
(Smart 2007). However adding too high concentration (5% NaOCl) reduced sensitivity 
(Smart 2007).  Thus, it can be observed that lack of standardization could explain 
inconsistencies in different reported smear results. A recent study by Bonnet et al (2008) 
which used more standardized procedures in fact showed a substantial increase in 
sensitivity of bleach sedimentation. 
 
The second problem deals with the manner in which smears were allocated to different 
techniques. In a study by Merid et al. (2009), TB suspects were requested to submit three 
sputum smears from which routine direct smears were prepared. The remaining sputum 
samples from the first spot, morning and second spot collection were pooled into one cup 
from which direct smear was prepared. Part of the pooled sample was concentrated using 
sodium hypochlorite (NaOCl) and the divided into three specimen for short term 
sedimentation, long term sedimentation and centrifugation technique.  On the other hand, 
a study by Lawson et al. (2006) used a different methodology. TB suspects were 
requested to submit a set of three sputum samples (first on-the-spot, early morning and 
on-the-spot). A routine diagnostic was performed on each of the specimen. Subsequently, 
one of three samples was randomised for digestive technique by adding household bleach 
(NaOCl) for sedimentation procedure. A second randomly selected sample was used for 
mycobacterium culture. The two studies clearly show differences in allocation of smears 
to the techniques. Such inconsistent patterns contribute to discrepancies in results. 
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However, a pattern regarding standardisation that seems to be coming up has had an 
impact on consistency of results. A study by Bonnet et al. (2008a) obtained significantly 
higher results for bleach treated specimen than direct smear microscopy. The 
standardised procedure permits a more universal diagnostic procedure for concentrated 
sputum processing techniques. 
 
Given the current evidence from studies using sedimentation and a variety of chemicals 
and the specific advantages of avoiding a centrifugation step, the overnight sedimentation 
approach with bleach and other chemicals seem to be promising processing methods that 
could be more feasibly implemented in resource poor settings.  Also, the fact that bleach 
is universally accessible at an affordable cost, gives hope that BS could even be more 
cost-effective than direct smear microscopy.  However, evidence on cost-effectiveness 
analysis (CEA) of BS still needs to be established.  Other concerns that merit further 
investigation include the fact that BS with longer sedimentation times would require that 
patients come to the health facilities at least twice more on 2 consecutive days (Merid et 
al. 2009). This may result in increased drop-out from the diagnostic process, particularly 
among those patients who have travelled long distances and/or who have few resources 
(Merid et al. 2009).  Such concerns warrant further investigation of use of shorter 
sedimentation times before prematurely disregarding the applicability of this approach. 
 
The next section presents empirical evidence on the CEA of the different sputum 
processing techniques.  Cost-effectiveness analysis is crucial given the costs and 
complexity of introducing a new diagnostic method.  The latter inevitably prompts 
Ministries of Health and technical agencies that support them to want solid data 
illustrating the benefits of new methods (Ramsay et al. 2006).  Policy makers also need to 
know if the new methods can be effectively implemented and sustained under certain 
budgetary constraints. 
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2.3 Cost-effectiveness analysis 
A search in different databases, which included PUBMED, EBSCO HOST, and some 
direct search from Google scholar, yielded only one cost effectiveness study that was 
conducted in a peripheral clinic of Kenya; a country in which 50% of individuals with 
tuberculosis are infected with HIV (Bonnet et al. 2008b). This study measured and 
compared the incremental cost per smear positive (SP) detected case of 10 different 
approaches; combining direct and/or bleach smear to diagnose TB. Overnight 
sedimentation was the approach used for the bleach sedimentation. Some of the 
combinations that were investigated include; 
 
(i) Direct smear on first specimen and direct smear on second specimen if the first 
specimen was negative. This was the standard. 
(ii) Bleach smear on first specimen 
(iii) Bleach smear on first specimen and bleach smear on second specimen if first 
specimen was negative. 
 
A decision analytical model was used to determine the approaches which were more cost-
effective.  Based on this model, the best and most cost effective approaches were to carry 
out option (ii) and option (iii) above.  Other alternative approaches that were also cost-
effective alternatives after excluding option (ii) and (iii) above included using direct 
smear on first specimen and bleach smear on second specimen if first specimen was 
negative. However, a major limitation of this alternative was the fact that patients would 
only receive their results on the third day, thus delaying TB diagnosis.  Direct smear on 
first specimen and bleach smear on first specimen if the first smear was negative, was 
also another approach that was considered a good alternative. However, this approach 
requires good specimen collection. 
 
One issue with the study by Bonnet at al. (2008) described above was the use of the 
incremental cost effectiveness ratio (ICER). The ICER represents the additional cost of 
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gaining one unit of outcome by a health care intervention when compared to the next best 
alternative in mutually exclusive interventions (Shiell et al. 2002). However, the ICER 
tends to be sensitive to small changes in average costs or efficacy. A small change in 
costs or effectiveness can result into large changes in ICER regardless of there being no 
statistical differences in costs and efficacy between the study groups (Gan and Lubarsky 
1999). In addition, a negative ICER may not provide meaningful values thus 
interpretation of ICER becomes generally difficult for policy makers to understand. On 
the other hand, average cost effectiveness ratio is more policy oriented. The format in 
which results are presented is similar to how budgets are formulated and allocated to 
various health interventions and as such policy makers find it easier to understand. 
Average costs are also preferred because of their ability to remain stable over a longer 
period thus suitable for long term planning. Average, like the marginal costs may only 
diverge substantially within a short period of time usually one year but also when fixed 
costs are high (Sinanovic and Kumaranayake 2006). 
 
The correct assessment of effectiveness is also essential. Bonnet et al. (2008b) used 
number of smear positive cases detected. This measure is perhaps the most relevant 
measure to use for measuring effectiveness of a method used to diagnose pulmonary TB. 
The importance of examining sputum is to ensure that patients with pulmonary 
tuberculosis are identified promptly and treated immediately before the disease can 
spread to close contacts. Since pulmonary tuberculosis is the most infectious type of TB 
it is critical that the disease be detected in the early stages so that it poses less threat to 
public health. An intervention that detects more of such cases would be the preferred 
intervention. An assessment of effectiveness would thus be how well new methods detect 
number of smear positive cases. 
 
Costs included in an economic evaluation are very critical not only because they affect 
the cost effectiveness ratio but also the interpretation of the cost effectiveness ratio. 
Direct costs are the most relevant since they reflect the cost of establishing or running the 
intervention. In their study, Bonnet et al. (2008b) used health service direct costs, which 
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also included labour cost, consumables and some patient’s transport cost estimates. A 
wider view of costs can be achieved by apportioning some of the fixed costs of facilities 
and administration to the costs of the service (Jamison et al. 2006). However, the 
researchers did not state whether capital costs were included and if they were included 
how they were apportioned to the intervention. In other studies, researchers have included 
opportunity costs such as the value of time patients and family members spend accessing 
health care, which is the loss in productivity. In addition, they also include transport costs 
to health facility.  Jamison et al. (2006) argue that when cost-effectiveness analysis 
includes more costs, the cost per unit of health gain appears to be higher and the 
intervention will appear to be less cost-effective. On the other hand, when too few costs 
are included, the cost per unit of health gain will be lower indicating that the intervention 
is highly cost-effective when actually may not be the case. 
 
2.4 Other studies on cost-effectiveness 
 
A study by Dowdy et al. (2003) looked at the cost-effectiveness of the Gen-Probe 
amplified mycobacterium tuberculosis direct test as used routinely on smear-positive 
respiratory specimens. The study used decision analysis approach to evaluate the cost-
effectiveness of programs in which the amplified mycobacterium tuberculosis direct test 
(MTD) (Gen-Probe) was compared to standard of care (no MTD). To determine validity 
of MTD test, culture was used as gold standard and number of early TB exclusion 
measured cost effectiveness, where early TB exclusion referred to number of tests with 
negative TB results (true negatives). Smear positive results were assumed culture positive 
for mycobacterium tuberculosis. The marginal cost of MTD test was US $330 per smear 
positive patient or US $494 per early exclusion of tuberculosis based on negative MTD 
results. The analysis also included costs of respiratory isolation and cost of drugs. MTD 
test was found not to be cost effective, however, in centralized laboratory MTD test was 
regarded as cost saving since large number of patients are treated per day. Like any other 
test, MTD test is not 100% efficient and this raised issues of false negatives where the 
test wrongly identifies a patient free of tuberculosis. Regardless of this, the benefits of 
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MTD test are greater especially considering that culture results may take long to be 
available. 
 
The study by Dowdy et al. (2003) used two effectiveness measures. They assessed 
effectiveness by number of smear positive case detected and also smear negative 
specimen. Many studies assess effectiveness by number of smear positive result (Dowdy 
et al. 2008, Walker et al. 2000). Conversely, Dowdy et al. (2003) used the Amplified 
Mycobacterium Tuberculosis Direct (MTD) test, which is an enhanced version, approved 
to be used in smear negative specimen. This permitted use of smear negative as an 
appropriate measure of effectiveness. In comparison to this study, the methods assessed 
were mainly designed to test smear positive TB cases; consequently, it was appropriate to 
measure effectiveness by smear positive TB cases detected. 
 
Another observation is that this study did not take into account HIV status of the patients 
being tested. HIV status is a major risk factor for TB and effectiveness of tests may be 
influenced by patient’s HIV status where results of HIV positive patients may be 
statistically different from HIV negative patients. The study used a wider view of costs 
where capital costs were apportioned to the techniques being investigated (Jamison et al. 
2006). Costs of drugs were estimated from central unit, which was also a major source of 
drugs in their country. Sourcing drugs from one major supplier ensures that there is less 
variability in costs. In addition, major suppliers reflect the true market value of the drugs. 
Unlike, where there are several suppliers, prices of drugs may vary from one supplier to 
another, more especially where prices of drugs and diagnostic materials are not regulated. 
There would be major differences as a result costing may not reflect what really health 
facilities incur to provide health care. 
 
A related study by van Cleeff et al. (2005) compared the cost-effectiveness of the routine 
diagnostic pathway using Ziehl-Neelsen (ZN) sputum microscopy followed by Chest X-
Ray (CXR) if case of negative sputum result (ZN followed by CXR) with an alternative 
pathway using CXR as a screening tool (CXR followed by ZN). The study enrolled 1389 
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suspects, among these 998 (72%) were enrolled for smear microscopy, culture and Chest 
X-Ray. Culture was used as gold standard. The study used laboratory costs and Chest x-
rays costs. Effectiveness was determined by the number of correctly diagnosed tests. The 
study found that the cost per correctly diagnosed case for the routine process was US 
$8.72, compared to US $9.27 using CXR as screening tool. Chest X-ray followed by 
Ziehl-Neelsen (ZN) sputum microscopy was more cost effective when costs of treatment 
were included otherwise excluding cost of treatment it is more cost effective to carry out 
ZN test followed by chest X-rays. Although chest X-ray has high sensitivity, they cannot 
distinguish between smear positive and smear negative patients making it difficult to 
determine infectious patients. 
 
2.5 Economic evaluation studies on TB in Malawi 
 
Malawi has limited record of economic evaluation studies on TB. Most of the studies 
done focused on equity and access to TB services. This subsequent section reviews one 
study that focussed on efficacy and another on cost effectiveness of TB interventions. 
 
A study by Hargreaves et al. (2001) investigated treatment outcomes of the cohort of 
smear-negative pulmonary TB (snPTB) patients in an area of high human 
immunodeficiency virus (HIV) seroprevalence. Patients about to be registered for snPTB 
treatment underwent further assessment including TB culture and followed up for 8 
months. The results showed that of the 352 snPTB patients assessed, 137 patients had 
bacteriologically confirmed TB. Death rate for non-TB case was 53%. The results 
suggest two things that can simultaneously be addressed by rigorous diagnosis of TB. 
Firstly, results suggest that there are more smear negative TB patients who are mistakenly 
given TB treatment resulting into poor outcomes. Secondly, in HIV positive individuals 
pulmonary TB is difficult to detect owing to low level of mycobacteria in HIV infected 
patients. This may enhance the spread of pulmonary TB to close contacts. A report by 
World Health Organisation (2007b) indicates that one untreated pulmonary TB case can 
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infect 10-15 people per year. Thus, it is increasingly important to explore different ways 
of improving the diagnostic yield so that more TB patients are identified and put on 
treatment within shortest possible period. This will then reduce transmission rates and 
improve treatment outcomes. 
 
Another study done in Malawi by Floyd et al. (2003) assessed the cost effectiveness of 
new treatment strategies for new pulmonary tuberculosis patients introduced in 1997. The 
first strategy was the strategy used until the end of October 1997 which involved two 
months of hospitalization at the beginning of treatment. The second strategy was the new 
decentralized strategy introduced in November 1997 where patients were given the 
choice of in or out-patient care during the two months of treatment. The two strategies 
compared were; one that did not require any direct observation of treatment (DOT) and 
the new community based strategy introduced in November 1997 which required DOT by 
a guardian who could either be a general community member volunteering to work or 
health worker. The guardian was needed for the first two months of treatment. Costs were 
analyzed using three perspectives namely; health services, patients, and the community in 
1998 (US$), using standard methods. Cost effectiveness was calculated as the cost per 
patient cured and the cost per patient completing treatment. 
 
Results indicated that for new smear positive patients, the cost per patient treated was US 
$456 with the conventional hospital based strategy and US $106 with the new 
decentralized strategy. The costs fell by 54% for health services and 58% for patients. 
The cost per patient cured was US $787 for the conventional hospital based strategy, and 
US $296 for decentralized treatment. The new method was more cost effective than the 
conventional hospital based. However, the results have a limitation of selection bias since 
patients were given a choice as to whether to stay in the hospital or be an outpatient. The 
severity of the disease might have influenced choice of patients; as such, patients 
recruited for each strategy might have been significantly different between the strategies. 
Those who are sicker might have chosen to take the hospital option and less sick opting 
for home based treatment. This would affect the effectiveness of intervention sites in 
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which case home based care may appear to be more effective than hospital based. In 
addition, given that sicker patients chose a hospital option, such patients are likely to 
incur more costs due to travelling than home based care and this would make hospital 
treatment less cost effective. Random allocation would have been the ideal criteria. 
Perhaps ethical issues associated with patient’s rights restricted random allocation of 
patients to different strategies. 
 
The challenge after identifying cost-effective intervention is to address concerns for an 
equitable distribution of health and health care. Major issues to consider include target 
population, people who may benefit from health interventions but also who will bear the 
costs involved.  The next section will look at the resource allocation. 
 
2.6 Resource Allocation 
 
Managers and policy makers usually encounter challenges in making decisions regarding 
allocation of resources in health care. Resource allocation (human and financial) to health 
interventions is often faced by multiple criteria such as budget constraints. Financial and 
human resources are always scarce to meet the demand. With regard to concentration 
techniques for Tuberculosis, challenges associated with centrifugation may impact 
heavily on health resources. Assuming the technique has been implemented, it may 
require that clinical officers and laboratory technicians dedicate more time to the new 
technique. This might involve shifting their attention from other interventions. In a 
setting where skilled health workers are very few, it may further strain the health sector 
resources. 
 
Other than time, the technique may also involve a number of additional financial costs 
such as cost of reagents. Centrifugation technique requires more diagnostic materials than 
direct smear microscopy which also increases the volume of materials to be purchased for 
the health facility. Other costs include; cost of purchase and maintenance of centrifuge; 
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more especially in Malawi where majority of health facilities do not have centrifuges, 
cost of training since most of the personnel may not be conversant with the new 
technique. Notably, most of the costs highlighted are not currently part of the costs in 
health facilities as such implementing such a method may involve shifting resources from 
other interventions to the new diagnostic method. Other health interventions may suffer 
because of such re-allocation. 
 
Similarly, with bleach sedimentation, unlike short sedimentation time, long sedimentation 
time may require additional time for laboratory technicians thus demanding an extra cost 
on the available resources. This might be at the expense of other health interventions. 
With many health interventions against limited resources, improvements in population 
health require not mere identification of what intervention works but also what works at 
least possible cost or what is cost effective (McDaid et al. 2003). Such useful information 
can be obtained from a cost effectiveness analysis. 
 
A cost effectiveness analysis also provides budgetary information on resources needed to 
roll out the program where the program is new. In addition, resource needed to expand 
the intervention to other districts or areas of the country; it also assesses the likely 
sustainability of the project/program over time since costs are monitored over time 
(Jamison et al. 2006). Such information is crucial for policy makers and is also more 
relevant for long term planning. 
 
However, resource allocation may not necessarily involve taking resource from one 
intervention to the new intervention. It may also involve re-allocating resources within 
the intervention. This will entail reallocating resources from less productive areas of the 
intervention. This promotes optimal use and delivery of the health intervention ensuring 
that there is no waste of resources (Hutubessy et al. 2003). 
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In addition, a cost effectiveness analysis helps to identify ways of reallocating resources 
to achieve more. It demonstrates not only the utility of allocating more resources from 
ineffective to effective intervention but also the utility of allocating resources from less to 
cost effective interventions. For example, National Center for Policy Analysis at Harvard 
University demonstrated that the number of life years saved could be doubled if resources 
were allocated to more cost effective interventions (Jamison et al. 2006). 
 
Internationally, cost effectiveness information has been used to identify disease control 
priorities in developing countries and essential health package (EHP) priorities. The EHP 
comprise of interventions that are feasible, cost effective (based on international data) 
and affordable (Ministry of Health 2002) but also those that have greater impact to reduce 
health burden of the population. In some countries, not only has economic evaluation 
helped to identify diseases priorities but has also become a requirement for public sector 
funding (Raftery 1998). For example, in Australia, pharmaceutical reimbursements are 
based on cost effectiveness analysis (IMS 2006). Such requirements ensure that public 
resources are effectively and efficiently used. 
 
In addition, many countries and organizations have demonstrated that cost effectiveness 
information can be used alongside other information to aid policy decision making 
(Hutubessy et al. 2003). Notably, when a cost effectiveness analysis has been applied 
appropriately and broadly to all social conditions and programs that significantly 
influence health, it may support use of resources that influence determinants of health 
(Dan and Daniel 2006). These determinants of health largely affect incidence of disease, 
disability and premature mortality, in which case, determinants of health can be targeted 
to reduce incidence of disease in the country. 
 
While cost effectiveness approach to resource allocation ensures maximum benefits for 
the given resources, in real life, rather than allocating all resources to cost effective 
intervention, equity concerns need to be addressed. This is especially more relevant in 
developing economies where resources are extremely scarce. Ignoring equity might put 
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other individuals at risk of life threatening health needs. Some authors have argued that 
allocation of resources using cost effectiveness analysis entails that resources be directed 
towards interventions that give more health gains. This ascribes a higher priority to those 
interventions which can cheaply or easily be provided (Dan and Daniel 2006). Those with 
health needs that require relatively more resources will lose out because their problem 
requires more resources and providing resources to their health problem will produce less 
health gains. For example, consider the hypothetical situation whereby 10 tablets are 
available for treating an ailment. In one case, there are five patients who need two tablets 
each to be cured. There is also another set of ten patients who need one each of the same 
tablets to be cured. Following a cost effectiveness analysis of resource allocation implies 
that maximum benefit will be achieved if only you serve the tablets to those who require 
one tablet only. However, such allocation will be very unfair to those who require two 
tablets to be cured. In such a case, a fair treatment would be a random way of giving 
treatment, which will ensure that patients have equal chances of getting treatment and 
being cured from the ailment. 
 
Nonetheless, a cost effectiveness analysis helps to identify the most deserving 
intervention and setting priorities on which interventions should be given more attention 
especially with budgetary constraints. In a resource-poor setting, it has become pertinent 
that health economic evaluations become part of the decision-making process for policy-
makers (Gold et al. 1996; Drummond et al. 2005). Medical interventions are not only 
required to be effective, they also need to maximize efficiency and make a favourable 
comparison with competing interventions (Drummond et al. 2005). There is a knowledge 
gap on the cost effectiveness of the new approaches to analyzing sputum, particularly 
relevant to a developing country context where tuberculosis is highly prevalent and 
resources are constrained. In an environment where resources are scarce it becomes 
increasingly important to critically evaluate different options. 
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2.7 Conceptual framework 
There are different forms of economic evaluations namely; cost minimization analysis, 
cost utility analysis, cost benefit analysis, and cost effectiveness analysis. The subsequent 
sections briefly explain each form of economic evaluation. 
 
Cost minimization analysis 
This is the simplest form of economic evaluation. The evaluation assumes that the 
outcome measure of the two or more comparators is equal; as such comparison is solely 
based on differences in costs (Shiell et al. 2002). The focus is to identify the least cost 
method. 
 
Cost effectiveness analysis 
Cost effectiveness analysis is a measure of economic evaluation that compares costs and 
outcomes of an intervention. This form of economic evaluation is mainly used where the 
interventions do not produce the same outcome (Robinson 1993). The method assumes 
that the interventions being investigated have different effectiveness. Outcomes are 
measured in single dimensional and measured in natural occurring units. For example, in 
assessing treatment options for tuberculosis, outcomes would be measured as number of 
TB patients cured. 
 
A lower cost effectiveness ratio is preferred because the alternative can produce more 
health benefits at a lower cost than the other. In a situation where an option is more costly 
and more effective than the current method, the incremental cost effectiveness ratio, a 
measure of cost per additional gain in outcome measure is used. Assessment is based on 
value judgment on whether the outcome is worth the additional cost (Shiell et al. 2002). 
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A cost effectiveness analysis requires correct measures of costs and outcomes. Measures 
of costs include the scope of costs. This varies from one program or intervention to 
another. 
 
Cost utility analysis 
This method enables broader comparison than cost minimization and cost effectiveness 
analysis. This method measures costs in monetary terms and outcomes in generic terms. 
These generic measurements include quality adjusted life year (QALYs), disability 
adjusted life years (DALYs) or health years equivalents (HYEs). Cost per unit output is 
derived as cost per QALY gained or cost per DALY lost. It allows assessment of both 
mortality and morbidity for a given intervention. 
 
Cost-benefit analysis 
This is an economic evaluation that enables broader comparison between alternative 
claims on societal resources (Shiell et al. 2002). It primarily addresses issues of allocative 
efficiency. The method values both costs and outcomes in monetary terms. It is rarely 
used because of the difficulty associated with valuation in monetary terms of intangible 
costs and benefits. Nevertheless, a cost benefit framework analysis is still useful because 
the impacts on costs and benefits can be presented in a balance sheet to highlight where 
trade-offs can be made. 
 
2.7.1 Types of costs 
 
Type and scope of costs depends on the perspective that a cost effectiveness analysis is 
taking. A provider perspective will only consider costs that are borne by the provider or 
the health facility.  A wider view of costs takes into account a societal cost in which case 
the analysis values all costs incurred by patients, provider and the society. In particular 
societal perspective considers the following costs; 
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Cost incurred by health facility. 
These include the time personnel spent in diagnosing TB which is valued by their 
monthly package; Maintenance cost of equipments, rent or cost of building; Operating 
costs such as costs of electricity, water and telephone. 
 
Costs incurred by patient 
These include transport costs to the health facility, food costs, opportunity cost of time 
lost due to illness, cost of user fees such as consultation, diagnostic, hospitalization and 
any other fee a patient pays to access health care. 
 
2.7.2 Measurement of costs 
 
Perspective of economic evaluation informs the scope of costs that have to be measured 
for an intervention. The most relevant are direct costs. These costs are valued at market 
prices. Essentially, valuing costs at market prices reflects the opportunity cost of using 
the input (Drummond et al. 2005). For example, laboratory personnel time can be 
measured by their remuneration package. Other direct costs such as diagnostic materials 
can be obtained from the major supplier. 
 
On the other hand, capital costs are valued slightly different. Capital costs do not only 
reflect opportunity cost of tying resources to equipment but also returns for the 
investment. As such, the measurement incorporates interest rates reflecting returns from 
an investment. In addition, as the capital item is being used the value decreases since the 
capital item wears off, thus the cost measurement also includes depreciation. To capture 
this, the capital item is annualized at a given interest rate and an annual cost of equipment 
is determined. 
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2.7.3 Allocation of shared costs 
 
Shared costs refer to those costs used by different programs in an organization. A staff 
member may be engaged in different interventions. For example, a lab technician may be 
involved in carrying out malaria tests, TB tests and HIV tests. In such cases, it becomes 
necessary to measure their time for the particular intervention under investigation, which 
in this study would be tuberculosis. The best criterion to assess time dedicated to an 
intervention is to actually record time personnel spend working on TB tests and 
determine the percentage of time dedicated to the intervention. Interviews with staff 
members involved also provide a reliable estimate. 
 
Shared costs also include capital items, which are used for other methods. Some capital 
items are allocated directly to cost centres while others use percentage of staff time 
dedicated to the intervention. 
 
2.7.4 Determining effectiveness 
 
Effectiveness is the measure of how well the method works. In TB management, several 
effectiveness measures have been used. Some studies have used conventional measures 
such as QALYs or DALYs while other studies have used natural units. For example, 
interventions aimed at measuring treatment outcomes have used number of TB cases 
cured. There are other interventions aimed at improving diagnostic yield. These also use 
natural units such as number of cases detected by each method. 
 
2.7.5 Source of effectiveness data 
 
Source of effectiveness data is critical for economic evaluations. The best source of 
effectiveness data for economic evaluation is a randomized control trial (RCT) 
(Drummond et al. 2005). Other than RCTs, effectiveness data can also be sourced from 
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non-randomized studies, cohort studies, case control studies and in extreme cases expert 
opinion. RCTs are preferred because they are less prone to selection bias since subjects 
are assigned randomly to intervention methods. 
 
2.7.6 Sensitivity Analysis 
 
Sensitivity analysis is a method of assessing uncertainty in economic evaluations. The 
analysis assesses robustness of the results by varying values of key variables across 
possible range. There are three major types of sensitivity analyses. 
 
Simple sensitivity analysis 
This varies one or more component of the evaluation across a possible range. The 
analysis can be one –way where one variable is changed at a time and the effects of 
varying the variable on the outcome observed. The sensitivity analysis can also be  multi-
way where more than two variables are changed simultaneously and effects of the change 
are observed. 
 
Monte Carlo Simulation 
This allows analysts to specify multiple ranges of values using computer-modelling 
software. Values are randomly selected by computer software from a specified 
distribution of variables. The method has an advantage of being able to deal with a large 
number of variables but also creates confidence intervals around the mean based on the 
selected range. 
 
Threshold sensitivity analysis 
A form of sensitivity analysis which uses the best case and the worst case approach. If 
two methods are being compared, the comparison is based on two extreme estimates; the 
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lowest cost and highest benefits (best case) are compared to highest cost and lowest 
benefit (worse case). 
 
Using sensitivity analysis, results of economic evaluation can be reported with certainty. 
Results are robust if changes in major epidemiological or economic variables do not 
significantly change mean cost effectiveness ratio. 
 
2.8 Summary of literature review 
 
This chapter reviewed literature that is relevant for this study. Literature on the 
effectiveness of different methods for diagnosing tuberculosis, compared with direct 
smear microscopy (DSM) was reviewed. These methods include: Polymerase Chain 
Reaction (PCR), Fluorescence Microscopy (FM) and sputum liquefaction followed by 
bleach sedimentation (BS) and bleach centrifugation (BS). Polymerase Chain Reaction 
and FM, though more specific than DSM, tend to be more expensive and hence less 
suitable for use in resource constrained settings. However, recent evidence on FM 
challenges this, and suggests that FM could have a role to play in resource poor settings. 
Nonetheless, the evidence base supporting this finding is still low.   
 
Several studies have supported effectiveness of natural sedimentation and centrifugation 
techniques with bleach. With regard to natural sedimentation, the majority of studies have 
supported longer sedimentation time than shorter ones. Still more, some studies have 
found that there is no significant difference in effectiveness when short or longer 
(overnight) sedimentation time is used. The fact that household bleach is readily available 
at an affordable cost also implies that bleach processing methods could be implemented 
successfully in resource poor settings. Nonetheless, certain concerns such as the limited 
financial resources to meet the recurrent cost of centrifuges and the cost of power 
required to run the machines still remain challenges that could hinder effective 
implementation of bleach centrifugation methods in resource poor settings.  In addition, 
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there seems to be very limited research on the cost-effectiveness analysis of these 
methods. However, one cost effectiveness analysis study that compared natural 
sedimentation and direct smear microscopy concluded that there is economic gain in 
using natural sedimentation than direct smear microscopy.  This study therefore indicates 
that bleach sedimentation is a promising approach of diagnosing TB in resource 
constrained settings.   
  
In a world of scarce resources, priorities have to be set on how resources should be 
allocated. The ideal situation is to allocate resources to interventions that give maximum 
benefits at least cost. An economic evaluation technique helps to inform this process. 
Even so, equity concerns still need to be considered when economic evaluation is being 
used as a resource allocation tool. 
 
This chapter concluded with a review of the principles of economic evaluation, different 
forms of economic evaluation and types of costs that are included in CEA and how they 
are measured. The different sources of effectiveness data as well as the different ways of 
measuring effectiveness in economic evaluation studies were also discussed.   
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CHAPTER 3 
 
METHODOLOGY 
 
3.1 Introduction 
 
The chapter presents the methods used in the study. These include the study setting, type 
of data utilized in the study, the perspective of economic evaluation, the measure of cost 
effectiveness, and sensitivity analysis used in the study. 
 
3.2 Study site 
 
The study sites include Bwaila Hospital and Malawi-Liverpool Welcome Trust. Bwaila is 
a tertiary hospital, situated in the capital city of Malawi-Lilongwe. It is primarily a TB 
hospital. It has bed capacity of 220 and serves a population of approximately 200 000. On 
the other hand, Malawi-Liverpool Welcome trust is a research centre situated in Blantyre, 
which is approximately 400 km away from Bwaila hospital. 
 
3.3 Choice of study sites 
 
Bwaila hospital was chosen as recruitment centre because it registers highest number of 
TB patients and is the main TB referral hospitals in Lilongwe-Malawi. Due to inadequacy 
of diagnostic equipment especially centrifuge for centrifugation technique, actual process 
of specimen for this study was done at Malawi-Liverpool Welcome Trust (MLW). 
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3.4 Perspective of the study 
 
This study adopted a provider’s perspective. Costs were estimated in 2008 Malawi 
Kwacha (MK) and then converted to United States dollars (US$) using the exchange rate 
of 2008. Outcomes were measured in terms of number of patients treated for TB and 
number of smear positive patients. 
 
Tuberculosis suspects (people who cough for at least 3 weeks) submit three specimen of 
sputum as recommended by Malawi National Tuberculosis Control Program (MoH 
2007). The three specimens from one patient were randomized to the three arms under 
investigation. To determine the validity of the test, culture was used as a gold standard. 
 
3.5 Description of alternatives 
 
Initially, sputum was analyzed using direct smear microscopy and, after smear positives 
and negatives were identified, samples, both smear positives and negatives, were 
randomly selected and tested using each of the three competing techniques. Laboratory 
technicians involved in the study were blinded on which specimens were smear negatives 
or smear positive. These techniques used in the study are described below; 
 
3.5.1 Bleach centrifugation 
 
Part of the specimen remaining from the direct smear microscopy was transferred from a 
wide mouth collection container into a sterile, 30ml universal container. An equal volume 
of freshly prepared (prepared same day) 3.5 % sodium hypochlorite solution was used to 
rinse out the wide mouthed container and added to the sputum in the sterile, 30ml 
universal container. The mixture was shaken by hand for 30 minutes during which it was 
shaken for approximately 7 times (at the start, after approximately every 5 minutes, and 
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at the end of incubation). Up to an equal volume of sterile distilled water was added to 
the mixture.  The mixture was then mixed by inversion several times and spun using a 
centrifuge at 3000 revolutions for 15 minutes.  The supernatant was decanted and 2 
smears, each containing 10ul of deposit, were made using sterile plastic calibrated loops. 
Slides were marked with a diamond marker to delineate the site of the material for 
microscopy. One smear was heat-fixed, stained using ZN (as described above) and 
examined for AFB using light microscopy. Positive smears were graded in accordance 
with the International Union Against Tuberculosis and Lung Diseases (IUATLD) system 
and all smear results were recorded.  The other smear was heat-fixed and archived under 
appropriate conditions. 
 
3.5.2 Bleach natural sedimentation 
 
An equal amount of freshly prepared 3.5% sodium hypochlorite (NaOCl) solution was 
added to the remainder of the specimen in the wide-mouthed collection container. The 
mixture was then shaken by hand for 20 seconds then placed at 45o
 
 to allow 
sedimentation into the dependent corner of the container and incubated at room 
temperature for 30-45 minutes.  At the end of this time, 2 drops of the sedimentation 
deposit were transferred from the digested sediment using a 2ml Pastette onto clean glass 
slides and allowed to air dry.  As in centrifugation, slides were marked with a diamond 
marker to delineate the site of the material for microscopy.  One smear was heat-fixed, 
stained using ZN and examined for AFB using light microscopy.  Positive smears were 
graded in accordance with the International Union Against Tuberculosis and Lung 
Diseases (IUATLD) system and all smear results were recorded.  The other smear was 
heat-fixed and archived under appropriate conditions. 
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3.5.3 Culture 
 
To determine the validity of the test, the remaining specimen was tested using culture 
method, which was the gold standard. A culture positive result is a definite TB case. 
The remainder of the specimen was transferred from the wide-mouthed collection 
container into a sterile, 30ml universal container. An equal volume of freshly prepared 
4% sodium hydroxide solution was used to rinse out the wide-mouthed container and 
added to the sputum in the sterile, 30ml universal container.  The mixture was mixed and 
centrifuged in accordance with the decontamination part of the Malawi Liverpool 
Welcome-trust TB culture protocol. Two smears, containing 10ul of the deposit were 
made using a sterile plastic calibrated loop.  Slides were marked with a diamond marker 
to delineate the site of the material for microscopy.  One smear was heat-fixed, stained 
using ZN and examined for AFB using light microscopy.  Positive smears were graded in 
accordance with the International Union Against Tuberculosis and Lung Diseases 
(IUATLD) system and all smear results recorded. The remaining smear was heat-fixed 
and archived under appropriate conditions. 
 
3.6 Data required and source of cost data 
 
3.6.1 Provider cost 
 
The analysis required data on annual cost of the personnel which included laboratory 
technicians, laboratory managers, administrative staff and cleaners, taken from 
payroll/pay scales based on their time. Other type of data required included cost of 
diagnostic materials, annual cost of building, annual equipment cost, operating and 
maintenance costs. This information was collected using two research tools, cost sheet 
and questionnaire (appendix C and D). A questionnaire was administered to personnel 
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working directly on the intervention while cost sheet was used to record various cost 
items and determining usage of materials. 
 
Data sources included financial reporting systems, expenditure and procurements records, 
central medical stores for diagnostic materials, equipment data was obtained from 
suppliers, cost of building obtained from building contractors and interviews with staff 
members. 
 
3.7 Costing 
 
Costing was undertaken retrospectively from a provider’s perspective. Costs were 
divided into recurrent and capital. An ingredient-based costing methodology was used 
where quantities of resources were multiplied by their respective prices to obtain total 
costs (Sinanovic and Kumaranayake 2006). Table 3.1 gives a summary of methods that 
were used to identify, measure and value costs. 
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Table 3.1: Costing Template 
Type of Cost Identification Measurement Valuation 
 Categories Costing method Source of data Valuation method Source of data 
Recurrent costs 
Personnel -Administration and 
laboratory staff (Lab 
technicians, assistants 
and managers) 
-Documented Staff 
time on these 
activities. 
-Total 
remuneration 
package costs. 
-Other external 
costs. 
-Record reviews 
- Interviews 
Total remuneration 
package 
Provider 
expenditure reports 
Supplies Stationary, Calibrated 
loops, universal 
container, diagnostic 
materials. 
Quantity consumed Procurement records Actual costs Central medical 
stores/ provider 
expenditure reports 
Building operating 
and maintenance 
costs 
-Overheads (electricity 
water and other 
utilities.). 
Telephone.-stationary, 
computer photocopier. 
-Actual costs from 
facility records. 
Facility records Time taken by each 
of the methods used 
Time sheet facility 
records/ interviews 
Capital Costs 
Building -Laboratory space. 
-Office space 
-Current 
replacement costs 
(building cost per 
m x square 
meterage of facility 
-30years life span 
-3% discount rate 
for annuitization 
Lab technicians/ 
managers 
-Replacement prices 
-Laboratory space 
used 
-Building and 
construction 
contractors. 
 
Equipment -Furniture, 
medical 
equipment 
(centrifuge and 
microscope) 
 
Actual replacement 
costs. 
-10years life span 
-3% discount rate 
for annuitization 
Laboratory 
technicians 
-Actual replacement 
prices. 
-Time usage. 
 
Central medical 
stores/local 
suppliers 
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3.7.1 Recurrent costs 
 
Recurrent costs included cost of volume of materials used in the study. Recurrent costs in 
this study include: 
 
a) Personnel (administration and laboratory staff time) 
b) Building and equipment operating and maintenance costs (e.g. maintenance of 
centrifuge, refrigeration costs, etc) 
c) Overheads such as water and electricity. 
d) Supplies (30ml universal container, sterile plastic calibrated loops, stationary such as 
diamond marker, pens, paper and storage boxes, and diagnostic materials (sticks, slides, 
preparation agents, bleach, vikon) 
 
Personnel costs were assessed based on the cost of the full benefits package for the 
personnel involved.  The benefit package included salary, bonus payments, gratuity 
payments or employer pension contributions, medical aid and any other direct costs of 
employment. 
 
3.7.2 Capital costs 
 
Capital costs refer to inputs or resources that usually last for more than one year such as 
buildings and equipment. Capital costs in this study included: 
 
a) Building (laboratory space) 
b) Equipment (microscope, centrifuges, bio-safety cabinets, fridge, autoclaving waste and 
slide drier) 
c) Furniture 
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The study used 30 years as useful life years for laboratory space, 10 years for centrifuge, 
5 years for furniture and 10 years for microscope. The study used a discount rate of 3% to 
annualize capital cost. These capital items were annualized to allow differential timing. 
 
3.7.3 Allocating shared costs 
 
The study had a number of shared costs such as cost of electricity, water, telephone, 
building furniture and equipment. Allocation to different techniques was based on staff 
time for a particular technique. The rationale was that we expected equipment to be used 
for the period during which the personnel involved in the study were working. For 
example, microscope was in use when laboratory technicians were conducting tests. 
Similarly, electricity was being used laboratory technicians were working on the 
specimens. 
 
Initially, number of hours spent by laboratory technicians for each method was estimated. 
Shared costs were allocated basing on the percentage time spent on the method. For 
example, if laboratory technicians spent 20% of their time on direct smear microscopy, 
then 20% of the total cost of electricity was allocated to direct smear microscopy. 
Similarly, same criteria were applied for natural sedimentation and centrifugation. The 
staff time used was based on the time of personnel who was actually using the equipment. 
For example, cost of furniture used by laboratory manager was based on the laboratory 
manager’s time dedicated to each method. 
 
Costs of some equipment were allocated directly to the relevant method. For example, 
annual and maintenance costs of a centrifuge were directly allocated to centrifugation 
technique. Supplies were directly allocated to different techniques. 
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3.8 Effectiveness  
 
Effectiveness data was obtained from a Randomised controlled trial (RCT) that took 
place at Bwaila hospital and Liverpool-Welcome Trust in Lilongwe and Blantyre 
respectively, and the researcher was granted access to the raw data (Chirambo et al 
2008). Sputum samples for the RCT were selected from the laboratory register of patients 
who had already submitted sputum as part of the routine diagnosis at Bwaila hospital. A 
total number of 912 patients’ samples sputum samples (spot, early morning and spot) 
were selected for TB examination. Half of the recruited patients (456) were smear 
positive patients and were matched with 456 smear negative patients. The selected 
samples were then transported to Liverpool-Welcome Trust in Blantyre. 
 
The selected samples were then initially examined using direct smear microscopy. The 
remainder of the specimen (a set of three) from each patient was randomized to 
centrifugation, natural sedimentation and culture. Smear positive TB patients were 
validated by culture which was the gold standard. A culture positive result was regarded 
as a definite tuberculosis case. 
 
Although 912 patients submitted sputum, some samples were lost due to leakage and 
contamination in transporting specimen to study area. As a result, only 807 patients’ 
samples were analyzed using natural sedimentation, 772 patient’s samples using direct 
smear microscopy and 771 patients’ samples were analyzed using centrifugation 
technique. Furthermore, a complete set of comparable specimen could only be obtained 
from 652 patient samples. As such, effectiveness analysis could only be performed from 
the complete set of comparable samples.  
 
Effectiveness was determined by number of smear positive TB cases detected. As 
discussed in the literature above, the approaches that were used in the RCT are designed 
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to improve diagnostic outcomes for pulmonary TB and it was necessary to use number of 
smear positive cases detected as a measure of effectiveness. 
 
Based on this data, sensitivity, specificity, and positive and negative predictive values 
were calculated. Table 3.2 below is a dummy variable indicating presentation of 
effectiveness results. 
 
Table 3.2: A dummy table for presentation of effectiveness data 
 Total 
number of 
patients 
screened 
for TB 
Smear 
positive TB 
patients 
Sensitivity Specificity Positive 
predictive 
values 
Negative 
predictive 
Direct Smear 
microscopy 
      
Natural 
Sedimentation 
      
Centrifugation       
 
3.9 Cost effectiveness analysis 
 
Cost effectiveness analysis is an economic tool where inputs are measured in monetary 
terms and outcomes in natural units (Drummond et al. 2005). It addresses issues of 
technical efficiency by evaluating alternative ways of achieving the same objective. The 
study assessed cost effectiveness using average cost effectiveness ratio where total cost 
for each method was divided by effectiveness measure.  The major outcome measure was 
the number of smear positive TB patients diagnosed for each method. But the study also 
calculated average cost per method so in essence two ratios were calculated, firstly, total 
cost were divided by total number of patients screened for each method. This was 
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basically an average cost. Secondly, total costs were divided by number of smear positive 
TB patients determined by each method. Unlike marginal costs, the average costs were 
preferred because of their relevance for national policy (Sinanovic and Kumaranayake 
2006). 
 
The study assessed the cost effectiveness by comparing average cost effectiveness ratios 
as given below. 
 
Average cost effectiveness ratio = Total costs of method Ai/Total number of smear 
positive detected by A
 
i 
Where Ai 
 
 is a method of analyzing sputum and ί can be direct smear microscopy, natural 
sedimentation or centrifugation technique. 
3.10 Sensitivity Analysis 
 
Sensitivity analysis helps to assess robustness of the findings to changes in key 
epidemiologic and economic variables (Walker 2001). The study performed two one-way 
sensitivity analyses. First, varying a percentage of staff time spent on each intervention 
method. The least possible time spent was assumed to be 25% less of the average staff 
time spent while longest possible time was assumed to be 50% more of average staff time 
spent on each method. Secondly, discount rate for annuitization of capital costs was also 
varied. A discount rate of 3% was used for the study and for purposes of sensitivity 
analysis, the discount rate was varied between 1% -5% and effects of variations were 
recorded. 
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CHAPTER 4 
 
STUDY FINDINGS 
 
4.1 Introduction 
 
This chapter presents study findings. Taking a provider perspective, the chapter gives a 
summary of the economic costs for each of the methods used for analyzing sputum, 
namely direct smear microscopy, natural sedimentation and centrifugation techniques. 
The chapter also gives effectiveness and average cost-effectiveness results. The findings 
of the sensitivity analyses are presented in the last section. 
 
4.2 Total provider cost 
 
Provider costs were grouped into recurrent costs and capital costs. Recurrent costs 
include personnel time, supplies (diagnostic materials used), building operating and 
maintenance costs. Capital costs include building, equipment and furniture. There were 
no training costs involved in this study. Costs were calculated in Malawi Kwacha (MK) 
and converted to 2008 United States Dollars (US$).  
  
Total provider costs (table 4.1) ranged from US $7,544 for natural sedimentation, US 
$12,279 for direct smear microscopy while centrifugation technique had total cost of US 
$8,859.  Total capital costs for natural sedimentation amounted to US $338 while direct 
smear microscopy incurred US $576 and centrifugation had total capital costs amounting 
to US $404. 
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Within methods, the greatest range was recorded for direct smear microscopy at US 
$6,622 followed by centrifugation technique at US $4,211 and least range being natural 
sedimentation at US $3,674. Natural sedimentation recorded the least total cost at US 
$7,544. 
 
Table 4.1: Total provider costs per method (in 2008 US$) 
 
The highest total costs were incurred through direct smear microscopy method at US 
$12,279. Total cost for centrifugation method was US $8,859 which was 14.84% higher 
than natural sedimentation. A similar trend in costs was also observed in total recurrent 
costs; direct smear microscopy incurred highest cost (US $11,702) followed by 
centrifugation (US $8,454) and finally natural sedimentation with total cost of US 
$7,205. 
 Direct Smear 
Microscopy 
(US$) 
Natural Sedimentation 
(US$) 
Centrifugation 
(US$) 
Recurrent Costs    
Personnel 4,212.94 3,689.80 3,689.80 
Supplies (Diagnostic materials) 6,647.90 2,995.23 4,227.70 
Building operating and 
maintenance costs 
841.75 520.30 536.67 
Total Recurrent Costs 11,702.58 7,205.33 8,454.17 
    
Capita Costs     
Building 25.00 15.71 15.71 
Equipment and Furniture 551.78 323.18 389.15 
Total Capital Costs 576.78 338.89 404.86 
    
Total Costs 12,279.37 7,544.22 8,859.17 
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Higher costs for direct smear microscopy were constantly observed for each of the cost 
category (figure 4.1). Highest costs were incurred in supplies and diagnostic materials. 
Supplies accounted for highest costs in centrifugation and direct smear microscopy while 
for natural sedimentation, personnel accounted for highest costs. Overall, personnel cost 
accounted for the second largest cost.  Lowest costs were incurred in capital costs with 
building recording the least costs.  Same amount of building costs were observed in 
natural sedimentation and centrifugation owing to equal time spent in carrying out tests. 
 
The higher cost in supplies for direct smear microscopy reflects the relatively more 
diagnostic materials required to determine patient’s TB status. While natural 
sedimentation and centrifugation with bleach is equally effective with single specimen 
from a patient direct smear requires three specimens from a patient (Lawson et al 2007). 
The more specimen needed for diagnosing TB translates to more staff time especially 
laboratory technician’s time, more reagents required and occupying more building space, 
thus the higher costs for direct smear microscopy. 
 
Figure 4.1 Total recurrent and capital costs (in 2008 US$) 
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Capital costs were relatively same for all the methods but recurrent costs exhibit a higher 
variability between the methods. The relatively same capital costs for the methods 
suggest that the provider cannot make significant savings by using either natural 
sedimentation or centrifugation. On the other hand, the wide range in recurrent costs 
suggests a potential target for reducing total costs. 
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Table 4.2 Percentage of total provider costs of TB diagnosis for each method. 
 
Results from table 4.2 display a significant variation in proportion of costs across 
methods. In each of the methods investigated, personnel and supplies accounted for the 
highest proportion (over 90% of total cost) for TB diagnosis. The high cost of personnel 
and supplies in direct smear microscopy is attributed to more specimens needed to 
diagnose TB patients which also translate to more time for laboratory personnel. On the 
other hand, natural sedimentation and centrifugation require a single specimen; though 
they require more diagnostic materials such as bleach, virkon disinfectants, carbol 
fuschin Stain, methlene blue stain, filter paper; these materials are relatively cheap such 
that their contribution to total cost for a single specimen is relatively lower thus lower 
proportion to total costs. The major contributors to supplies were costs for Calibrated 
loop, autoclaving bags, applicator sticks, gloves and pipettes, which were used by all the 
 
Direct Smear 
Microscopy 
Natural 
Sedimentation Centrifugation 
Recurrent costs    
Personnel 34.31 48.91 41.65 
Supplies (diagnostic materials) 54.14 39.70 47.72 
Building operating and maintenance 
costs 6.85 6.90 6.06 
Total recurrent costs 95.30 95.51 95.43 
    
Capital Costs    
Building 0.20 0.21 0.18 
Equipment and furniture 4.49 4.28 4.39 
Total capital costs  4.70 4.49 4.57 
    
Total costs 100.00 100.00 100.00 
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three methods studied as such for single specimen methods, costs of such materials, were 
much lower. 
 
Capital costs have least proportion across the methods suggesting low usage of 
equipment of materials and relatively lower costs of space used. The TB laboratory for 
this study was relatively small and one major office was used for personnel, which really 
reduced capital costs. Besides that, specimens were sent in a package once a week to 
Welcome Trust (study site) which meant two days of week’s working days utmost three 
were mostly utilized for the study. 
 
4.3 Average provider costs per patient diagnosed for pulmonary tuberculosis 
 
Average provider cost, exhibit a high variability between methods (table 4.3), with direct 
smear microscopy indicating the highest average cost (US $16). The high average cost 
reflects the higher cost for diagnostic materials and more personnel time need to carry out 
the tests. Least average cost was incurred in natural sedimentation (US $9) while 
centrifugation technique (US $12).  
 
The cost for supplies in natural sedimentation was far much lower than half of the cost of 
supplies for direct smear microscopy (US $4 vs. US $9), reflecting the lower cost of 
additional materials used in natural sedimentation, such as bleach. Bleach is locally found 
and very cheap. There is a smaller difference in personnel average cost for direct smear 
microscopy and natural sedimentation owed to ¾ of an hour  as sedimentation period for 
specimen before they are examined for presence of tuberculosis bacteria. Direct smear 
microscopy indicates a higher average cost for equipment and furniture than natural 
sedimentation.  The high equipment costs in direct smear microscopy emanates from the 
longer diagnostic time suggesting that equipments were used for  longer time hence 
higher cost. In addition to that direct smear microscopy requires more specimens which 
implies more time for equipment which results into higher equipment costs 
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Table 4.3: Average provider costs of analyzing sputum from recruitment to results 
recording per patient diagnosed. 
  
The denominator for average costs was based on number of sputum test that were 
performed by each method. Due to leakage in some specimen, natural sedimentation 
method was performed on 807 patients while direct smear microscopy had 771 patients 
and centrifugation technique was performed on 772 patients. 
 
Comparing natural sedimentation and centrifugation technique, table 4.3 indicates that 
natural sedimentation had lower cost almost in all cost categories. Notably, total 
personnel costs for both methods were equal, however, natural sedimentation has lower 
average cost due to slightly more specimen analyzed (807 vs. 771) than centrifugation. 
There is also a significant difference in average cost for supplies, reflecting slightly more 
 
Direct Smear 
Microscopy 
Natural 
Sedimentation Centrifugation 
Recurrent costs    
Personnel 5.46 4.57 4.78 
Supplies (diagnostic materials) 8.62 3.71 5.48 
Building operating and 
maintenance costs 1.09 0.64 0.70 
Total average recurrent costs 15.18 8.93 10.95 
    
Capital costs    
Building 0.03 0.02 0.02 
Equipment and furniture 0.72 0.40 0.50 
Total average capital costs 0.75 0.42 0.52 
    
Total average costs 15.93 9.35 11.48 
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diagnostic materials used (filter paper and Virkon disinfectants) for centrifugation than 
natural sedimentation. Average cost for equipment is also higher for centrifugation. 
Unlike natural sedimentation, centrifugation requires use of additional equipment, 
centrifuge, which rotates at various speeds about a central point and separates liquids of 
different densities by centrifugal forces. As a result the method has greater costs for 
equipment than direct smear microscopy. 
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Table 4.4: Percentage average provider costs of analyzing sputum from submission 
of specimen to reporting of results, 2008 US$ (% of total). 
 
Results from table 4.4 indicate similar trend in output to results in table 4.2 with total 
recurrent costs accounting for over 95% of total cost across the methods. Building and 
maintenance costs have similar proportion across the methods, reflecting similar cost for 
building, operating and maintenance costs of materials. Capital costs also exhibit similar 
trend and almost same percentage contribution to total average costs within each method. 
 
 
 
 
 
Direct Smear 
Microscopy 
Natural 
Sedimentation Centrifugation 
Recurrent costs    
Personnel 34.27 48.88 41.64 
Supplies (diagnostic materials) 54.11 39.68 47.74 
Building operating and 
maintenance costs 6.84 6.84 6.10 
Total average recurrent costs 95.29 95.51 95.38 
    
Capital costs    
Building 0.19 0.21 0.17 
Equipment and furniture 4.52 4.28 4.36 
Total average capital costs  4.71 4.49 4.53 
    
Total average costs 100.00 100.00 100.00 
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4.4 Effectiveness 
  
This section presents results of the effectiveness analysis. As indicated in the 
methodology, data for effectiveness was obtained from a Randomized Controlled trial 
(RCT). Sensitivity and specificity were obtained from the analysis of the RCT (Chirambo 
et al. 2008). Total number of smear positive cases detected by each method was 
quantified by a simple descriptive analysis in STATA version 10.  
   
The results (table 4.5) indicate that direct smear microscopy detected 325 smear positive 
TB patients while natural sedimentation detected the least number of smear positive 
patients (293) and centrifugation method detected 314 smear positive TB patients.  Direct 
smear microscopy was the most effective than natural sedimentation and centrifugation 
as indicated by total number of smear positive patients detected. Other studies have 
reported higher sensitivity and more smear positive cases detected. One possible reason 
could have been the transferring of specimen from recruitment centre (Lilongwe) to study 
area in Blantyre. It was observed that during courier of samples almost one third of 
specimen were contaminated which were not tested. Contamination might have been 
reduced by carrying out the tests within the same health facility. Nevertheless, the report 
from the RCT indicates that concentration techniques were more sensitive than direct 
smear microscopy (Chirambo et al. 2008). Natural sedimentation appears to have higher 
sensitivity (80.90% vs. 74.60%) than centrifugation. However, specificity was higher for 
centrifugation. 
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Table 4.5: A summary of patients’ outcomes, sensitivity, specificity and total smear 
positive patients. 
 
In addition the report (Chirambo et al.2008) indicate that most of the specimens achieved 
a more positive grade that is from scanty to 2+ and 3+ which confirms that concentration 
techniques were more sensitive than direct smear microscopy.  
 
4.5 Cost-effectiveness 
 
Taking a provider perspective, results show that the most cost effective method of 
analyzing sputum is natural sedimentation with average cost effectiveness ratio of US 
$26 per smear positive patient detected (table 4.6). Natural sedimentation has also 
reflected higher sensitivity than centrifugation and direct smear microscopy. The least 
cost effective was direct smear microscopy where the provider incurred the highest cost 
(US $18). However, this method also identified highest number of smear positive TB 
cases suggesting that it has highest effectiveness compared to other methods. 
 
 
Method Sensitivity Specificity 
Total 
patients 
tested 
Smear positive 
patients 
Direct Smear 
Microscopy - - 652 325 
Natural 
Sedimentation 80.90% 67.60% 652 293 
Centrifugation 74.60% 69.70% 652 314 
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Table 4.6: A summary of costs, effectiveness and average cost- effectiveness ratios 
(Cost in 2008 US$). 
 Total 
Cost 
(US$) 
Total 
number 
of 
patients 
Total 
number of 
smear 
positive 
patients 
Average cost 
per patient 
diagnosed 
(column 
2/column 3) 
Cost per smear 
positive patient 
(column 
2/column 4) 
Direct Smear 
Microscopy 
12,279.37 771 325 15.93 37.78 
Natural 
Sedimentation 
7,544.22 807 293 9.35 25.75 
Centrifugation 
 
8,859.03 772 314 11.48 28.21 
 
4.6 Sensitivity Analysis 
 
Sensitivity analysis shows robust results with cost and cost effectiveness assumptions not 
sensitive to variation of discount rate (table 4.7). However, these assumptions were 
sensitive to changes in staff time. For example, natural sedimentation had highest 
(26.88%) percentage divegence from base case. Despite of the changes in staff time, cost-
effectiveness ranking remained the same. Natural sedimentaion technique still remained 
the most cost effective method, followed by centrifugation. 
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Table 4.6: A summary of sensitivity analysis. 
  
 
 
 
 
Direct Smear 
Microscopy 
Natural 
Sedimentation Centrifugation 
Alternative estimates of provider costs (Staff time)    
Lower limit 25%less staff time    
% Divergence from base case provider cost estimate -10.25 -13.34 -11.47 
% Divergence from base case provider cost effectiveness estimate -10.25 -13.40 -11.55 
% Divergence from base case provider cost effectiveness estimate 
per smear +ve patient -10.24 -13.36 -11.41 
    
Upper limit 50% more staff time    
% Divergence from base case provider cost estimate 18.58 26.84 20.65 
% Divergence from base case provider cost effectiveness estimate 18.59 26.88 20.6 
% Divergence from base case provider cost effectiveness estimate 
per smear +ve patient 18.57 26.83 20.67 
    
Discount  rate    
Lower limit 1% discount rate    
% Divergence from base case provider cost estimate -0.69 -0.66 -0.55 
% Divergence from base case provider cost effectiveness estimate -0.69 -0.69 -0.59 
% Divergence from base case provider cost effectiveness estimate 
per smear +ve patient -0.69 -0.66 -0.53 
    
Upper limit 5% discount rate    
% Divergence from base case provider cost estimate 0.76 0.72 0.81 
% Divergence from base case provider cost effectiveness estimate 0.74 0.69 0.81 
% Divergence from base case provider cost effectiveness estimate 
per smear +ve patient 0.74 0.7 0.82 
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4.7 Summary 
 
The chapter presented costs, effectiveness and cost-effectiveness of direct smear 
microscopy, natural sedimentation and centrifugation techniques. Natural sedimentation 
was found to be the most cost effective with least cost though with least number of TB 
patients detected. It was followed by centrifugation, which is also highly effective. Direct 
smear microscopy was the least cost effective method owed to large number of specimen 
needed to diagnose a patient, which increased cost of diagnostic material and the cost of 
time laboratory technician spend to carry out TB tests. The new methods have shown 
higher sensitivity. 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
  
 
56 
CHAPTER 5 
 
DISCUSSION 
 
5.1 Introduction 
 
This chapter discusses the main study findings. The chapter highlights merits and 
demerits of the methods used. It also draws some lessons presented in literature and 
compares results with some similar studies done in Malawi and other countries. 
 
5.2 Brief summary of study findings. 
 
The cost effectiveness analysis showed that natural sedimentation is the most cost 
effective method of analyzing sputum and direct smear microscopy the least cost-
effective technique of the three techniques evaluated in the study. The total cost of direct 
smear microscopy is almost twice the total cost of natural sedimentation. Though least 
cost, natural sedimentation was also the least effective method. The results also indicated 
that centrifugation technique is more effective than direct smear microscopy. 
 
5.3 Discussion of results 
 
Annually, about 27,500 patients are diagnosed for tuberculosis in Malawi. Based on our 
findings, this would cost approximately US $438,075 for direct smear microscopy. The 
same number of patients would approximately cost US $257,125 for natural 
sedimentation. Comparing total annual cost for direct smear microscopy and natural 
sedimentation, the method would save about US $180,950 per year reducing the total 
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expenditure for TB diagnosis by almost 41%. Similarly, centrifugation technique would 
cost US $315,700 saving US $122,375 (28% of cost for direct smear microscopy) per 
year. 
 
Looking at the macro budget for 2008 and taking an exchange rate of K140.53 to US $1, 
the annual budget for health sector was about US $224,285,714 (Goodall 2008). The 
savings made from natural sedimentation would be 0.08% of the total health sector 
budget. This is a significant amount especially in a country highly dependent on donor 
funding. Implementing cost effective methods would help reduce budget deficits and 
reliance on donor funding. Recently, it has been observed that donor funding is 
dependent on political situation of the country and where the donors are not impressed 
with government’s financial management; they pull out their financial support as 
evidenced by several African countries which have suffered freezing of donor funding 
(Linskkey 2009). For example, in Malawi between 2001 and 2003, the government was 
regarded as highly corrupt and this prompted donor countries to pull out their resources 
(Tenthani 2002). Another example is the recent situation in Zimbabwe where donors 
pulled out due to political intolerance and human rights violation. This resulted into a 
collapse of the health care in public facilities (Linskey 2009). Similar situation has been 
witnessed in Zambia; Kongo Times of 20th
 
 June 2009 reported that health funding was 
frozen after alleged financial mismanagement. All these examples suggest the 
disadvantage of heavy reliance on donor funding. In an event where government can 
effectively use resources within the economy by implementing cost effective methods, 
reliance on donor funding would be reduced. Besides reducing budget deficits, saved 
resources would be used to finance other health intervention and further improve 
population health. 
The results of this study are similar to those of a study done in Kenya where a simple 
decision analytical model was used to look at the cost effectiveness of added value of 
bleach sedimentation microscopy for TB diagnosis (Bonnet et al 2008b). However, their 
study looked at incremental cost-effectiveness of bleach sedimentation whilst this study 
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focused on average cost effectiveness. Besides that, this study also looked at bleach 
centrifugation technique. Study results showed that bleach sedimentation on 1st specimen 
was the most cost effective strategy (US $2 per smear positive case detection rate) 
followed by bleach smear on 1st specimen and 2nd specimen than direct smear microscopy 
technique (Bonnet et al. 2008b). The findings are similar to this study finding though the 
cost effectiveness ratio was considerably lower than the cost effectiveness ratio in this 
study. Their study showed that the best alternative was to carry out direct smear on 1st 
specimen and bleach smear on second if 1st
 
 specimen is negative. But the problem would 
be that patients would only get the results on a third day which will then increases 
transportation costs for the patient and delay initiation of treatment assuming the patient 
is sputum smear positive. 
Notably, the highest burden of TB is found in poor countries and within countries the 
prevalence of TB is higher among the poor (Kemp et al. 2007). In Malawi, though TB 
treatment is free of charge at point of delivery, the poor reported spending 244% of their 
total monthly income on TB diagnosis, compared with 129% of the non poor (Kemp et 
al. 2007). Most of these expenditures were a result of transport and food while accessing 
health care as such reducing number of hospital visits through improved diagnosis can 
reduce economic burden of TB diagnosis for the poorest. 
 
There would also be a decrease in opportunity cost. Most of the TB patients go to health 
facilities with guardians which means both patient and guardian are not productive at that 
particular time. If you have more visits there is a greater loss of productivity as is the case 
with direct smear microscopy. As such, reducing number of visits will fundamentally 
reduce costs thus making current method more costly over these new techniques. 
 
Bonnet et al. (2008b) observed that a second best alternative was to carry out a direct 
smear on 1st specimen and bleach smear if 1st specimen was negative but this would 
require collecting a good specimen. A good specimen is regarded as the early morning 
specimen (van Deun et al. 2002). Getting a good morning sputum specimen is essential 
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for AFB test since they are likely to contain bacilli because secretions tend to build up in 
the airways overnight (Smart 2007) making it a highly efficient specimen for TB 
diagnosis (van Deun et al. 2002). Even in normal TB diagnosis, where three specimens 
are tested for presence of AFB, a good specimen is still essential for improved sensitivity 
of the specimen. 
 
Like this study, Bonnet et al. (2008b) did not take into account patient’s perspective. 
However, they estimated transport cost that captured some of the patients’ costs. In 
comparison, this study did not take into account patient’s costs. Nevertheless, the use of 
single sputum specimen for same-day result would mean that patients would incur fewer 
costs in obtaining diagnosis. Normally, patients submit sputum on spot specimen, another 
evening and morning, which means it takes two days to submit specimen then a third day 
for collection of results. Such multiple visits would be minimized in centrifugation and 
sedimentation techniques since a single specimen would be required to determine 
whether a patient has tuberculosis or not. 
 
This study also suggests that patient’s costs would also be the same for bleach 
sedimentation and techniques since patients will have almost same waiting time and will 
not need to come back to collect results. Diagnostic time for sedimentation and 
centrifugation techniques were almost the same so we do not expect to have differences 
in patient costs between the two methods. Other studies used longer sedimentation time. 
For example, Bonnet et al. (2008b) used overnight sedimentation in which case, we 
would expect bleach sedimentation technique to have more patient costs than 
centrifugation due to multiple visits. Longer sedimentation time would also result into 
more workload for laboratory technicians. 
 
Much as the calculation of cost effectiveness seems to be easy, choices about units of 
measurements and scope of the costs included alter the numerical results (Jamison et al. 
2006). This also affects the interpretation of results. This study results show higher cost 
effectiveness ratio for direct smear microscopy compared to study results of van Cleeff et 
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al. (2005). They reported a much higher cost effectiveness ratio of US $8.72 compared to 
this study’s US $38.98 for direct smear microscope. Regardless that these studies were 
done in different settings but the scope of costs used could explain the large difference in 
cost effectiveness ratios. They used laboratory costs only while in our study we included 
direct administrative costs. This could have increased the costs in our method hence 
increasing the cost effectiveness ratio. 
 
5.4 Benefits and constraints of the methods 
 
5.4.1 Natural sedimentation. 
 
Bleach sedimentation could be the most realistic choice to aid the expansion of TB 
microscopy to the community (Dacombe et al. 2006). Besides being cheap, its widely 
available chemical which makes it suitable to be used in rural health facilities. In 
addition, it does not require additional equipment to perform a test. Unlike the 
centrifugation technique, though highly effective, cannot be operational in most of the 
health facilities. Firstly, because of the need for electricity since most of the rural health 
facilities do not have reliable electricity which makes centrifugation a nightmare to 
implement in peripheral laboratory circumstances in Malawi. Secondly, centrifugation 
also needs special expertise and the risk of infection for using improperly maintained 
centrifuges may also be a major concern with current shortage of health workers it may 
not be realistic to implement the method. The Malawi Ministry of Health (2008) reports 
that in 90 microscopic centers there are 191 laboratory technicians and most of these 
personnel are concentrated in facilities with huge workload such as central and district 
hospitals. This suggests that some health facilities have no laboratory technicians as such 
expanding microscopic centers should commensurate with an increase in health worker, 
without which may not be realistic. 
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Although the bleach sedimentation slightly increased sensitivity than direct smear 
microscopy, it has the intrinsic advantage of disinfecting (Dacombe et al. 2006); once 
sample has been processed it becomes mucoid rendering it less infectious, thus safer, and 
easier to work with. Making the work safer may remove some of the concerns about 
employing less skilled workers, which has lately been common in Malawi especially with 
shortage of health workers. There has been a shift of tasks in such a way that some of the 
work supposed to be done by doctors was shifted to nurses, some of the work for nurses 
was shifted to clinicians and finally down the line, work was also shifted to guardians. 
Though it has lessened the shortage of health worker but the risk of infection involved 
would be the greatest concern as such strategies that improve safety of worker will 
increase work morale among the health workers. The results of this study also exhibited a 
shift of smear results in terms of grading system. It was observed that after adding bleach, 
both methods showed more specimens shifting from scanty to attaining higher positive 
grade confirming the assertion by microscopists that adding bleach renders the specimen 
easier to read (Dacombe et al. 2006). Thus reducing time taken to read slides and in the 
process improving efficiency. 
 
5.4.2 Bleach Centrifugation 
 
Bleach centrifugation is more effective method than direct smear microscopy. It is highly 
sensitive as evidenced by the number of smear positive patients detected. The ability to 
determine larger number with a single specimen can be attributed to clearer microscopic 
field with reduced debris. Like bleach sedimentation, bleach centrifugation has protective 
effect of disinfecting the specimen thus rendering it less infectious and easy to work with 
in the laboratory. However, bleach centrifugation is capital intensive. It requires well 
skilled workers to operate the centrifuge. In addition, cost of purchasing and maintaining 
the machine may strain the resources for the health sector. The machine also requires 
steady supply of electricity which makes it suitable to be effectively used in major 
hospitals such as central, district and Christian Health Association of Malawi (CHAM) 
hospitals. Implementing centrifugation technique may not be realistic in Malawi’s health 
sector especially with the current shortage of health workers. Although there are some job 
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shifts as highlighted above, less skilled workers may not easily handle this technique or 
may compromise quality of work. 
 
The new methods discussed have the potential of not only reducing workload but also 
improving diagnosis of TB. The WHO 2008 global report estimates that Malawi has 
approximately 50,000 TB cases annually (WHO 2008). However, only 50% of these 
cases are identified and treated (Banda 2009). This implies that the remaining 50% 
potentially transmit the disease to the general population. The consequences of such 
undiagnosed TB cases include high rates of transmission since TB has a long period of 
infectiousness. The disease could be passed on to several people. The World Health 
Organization 2005 fact sheet estimates that one active TB case that is left undetected can 
potentially infect about 15 people per year (WHO 2005). This means that every year 
there would be more TB cases in the country which would put pressure on the health 
sector’s human and financial resources. As a result it may be very difficult to control the 
disease.  
 
 
5.5 Reliability of the study findings 
 
5.5.1 Use of micro and ingredient based costing 
 
Micro costing is a valuation method in health economics that attempts to measure costs 
and benefits of the service as accurately as possible (Smith et al. 2005).  Accurate 
estimation of costs and effectiveness of the health intervention is the major strength of 
cost effectiveness analysis (Smith et al. 2005). The main focus is high level of precision 
regarding the delivery of service from which highly specific policies can be drawn. There 
are three approaches of doing micro costing namely; direct measurement where inputs 
such as staff time and supply are directly measured to develop a precise cost estimate. 
The second approach is use of pseudo-bill and finally regression analysis. Pseudo-bill use 
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stored data from government department while regression analysis uses regression 
technique to estimate cost of services. This study used direct measurement approach and 
tried to accurately measure cost of materials used so that results are reported with 
certainty. Micro costing also allows for making interesting extrapolations, which may 
trigger debates on areas of health care provision. The sampled costs can be extrapolated 
to national. For example, the expected total expenditure in the health sector could be 
estimated. 
 
The study analysis also used ingredient costing which works on the same principle of 
micro costing. Materials used in delivering health care are valued such as time workers 
spend and actual materials used per patient. The cost of each material per patient is 
estimated and multiplied by quantity to get the cost of materials used per patient. These 
approaches support reliability of study results. 
5.5.2 Use of data from a randomized controlled trial 
 
Randomized controlled trials are rated the best source of effectiveness data for economic 
evaluation. Their intrinsic feature of random allocation of specimen to intervention group 
(Sibbald and Roland 1998) minimized selection bias. Analysis was based on groups as 
allocated thereby ensuring that differences between groups were by chance alone. 
Secondly, its ability to deal with ascertainment bias and minimize co-intervention bias by 
blinding the trialists/ laboratory technician as to which treatment was given to what 
method until the end of the study (Prescott et al. 1999). Bias was also minimized by 
employing clearly described treatment policies for each method that were followed 
consistently. 
 
5.6 Limitations of the study 
 
5.6.1 Variability of bleach quality. 
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Bleach is easily accessible and locally found at a very low cost. However, there are 
several issues surrounding its use. The optimal storage temperature has not yet been 
determined which might be a major concern because if the concentration levels change 
due to temperature, higher concentrated bleach has been associated with poor outcomes. 
As such, a standardized bleach concentration has to be maintained at all times. 
Inconsistency in concentration of bleach may result in poor outcomes. 
 
5.6.2 Absence of patient’s cost perspective 
 
The study did not take into account patient’s perspective. However, with the new sputum 
processing methods analysis, patients are likely to incur less costs since they will obtain 
on spot results as such they will not make multiple visits which increases transport, food 
and opportunity costs patients incur. The new methods will still be more cost effective 
than currently used direct smear microscopy method. Looking at the diagnostic time 
between centrifugation and natural sedimentation technique, patients are expected to get 
results within same time as such we would still expect in overall, natural sedimentation to 
be more cost effective over centrifugation. 
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CHAPTER 6 
 
CONCLUSIONS AND POLICY RECOMMENDATIONS 
 
6.1 Study conclusions 
 
Natural sedimentation method is more cost effective than centrifugation and the direct 
smear microscopy. Diagnosing TB suspects using natural sedimentation would save 
about 41% of TB diagnosis related costs in form of staff time and diagnostic materials. 
The saved staff time would be redirected to other interventions. At the same time the 
shortage of health workers especially laboratory technicians would be lessened. The 
major concern is the lower effectiveness though the method had the highest sensitivity 
than centrifugation. This might reduce number of patients detected for TB though 
lowering costs by almost 41% of diagnosing TB. Regardless of the lower effectiveness, 
bleach has the potential to reduce transmission especially to those who directly process 
sputum. 
 
Centrifugation with bleach is more cost effective than direct smear microscopy. It is a 
best alternative to direct smear microscopy since it detected almost same number of 
tuberculosis patients. Implying that it is equally effective than the current method but also 
cost saving. The disadvantage is that it requires special expertise in using centrifuge that 
makes it not suitable in the Malawi context. In addition, most of the rural hospitals do not 
have a reliable source of electricity as a result it may not be implemented in most of the 
peripheral hospitals and health facilities. 
 
Direct smear microscopy was the least effective method. However it detected the highest 
number of tuberculosis cases. This could be attributed to the use of three specimens in 
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detecting tuberculosis in which case if a morning specimen produced a negative result, 
the spot might be positive thereby increasing chances of capturing all TB patients. 
6.2 Recommendations 
 
There is an urgent need for policy change in implementing cost effective case finding 
methods for pulmonary tuberculosis in Malawi. Currently, directly smear microscopy is 
the major case finding for pulmonary tuberculosis where patients submit three sputum 
specimens to examine presence of mycobacterium for detecting tuberculosis. However, 
the associated low sensitivity has been a major concern for tuberculosis control.  Thus 
improvements with concentration technique such as centrifugation and sedimentation 
would be timely and desirable especially now with the high prevalence of HIV/AIDS 
where case finding for tuberculosis with direct smears microscopy tends to be even 
difficult. 
 
Tuberculosis related millennium development goals target detection rate of 70% and cure 
rate of 85% by 2015 (Baltussen et al. 2005). Currently there have been some considerable 
improvements in working towards attaining TB related millennium development goals. 
With such improvements incorporating strategies that reduce costs such as diagnosing TB 
by natural sedimentation with bleach may be cost saving and could substantially reduce 
expenditure on TB diagnosis. 
 
The improved sensitivity reflected in results section imply that the natural sedimentation 
detect TB in people with lower number of mycobacterium, especially those who are HIV 
positive. In such patients, TB could be detected promptly and patients put on treatment in 
their early stages. An improvement in case finding is desirable towards attaining 
tuberculosis related millennium development goals. Implementing these techniques 
would improve not only case detection but also cure rates since patients will be diagnosed 
early and put on treatment in early as such they could be able to respond well to 
treatment. It would also reduce transmission rates to close relatives and the public. TB 
Un
ive
rsi
y o
f C
ap
e T
ow
n
  
 
67 
infection among health worker has also been a major concern in Malawi (Harries et al. 
1999). However, with bleach concentration techniques, such concerns will be implicitly 
addressed since bleach digests sputum making it less infectious and easy to work with 
thereby increase safety of specimen to clinicians (Dacombe et al. 2006). 
 
Malawi, like many other Sub-Saharan countries face shortage of health workers. While 
government trains few health workers, of the few, some have migrated to European 
countries for greener pastures. Natural sedimentation method could potentially reduce 
laboratory workload significantly. Reducing workload for the few available health 
workers would positively increase their work morale. There could be less time devoted to 
diagnosis but at the same time not compromising quality of diagnosis. 
 
Natural sedimentation with bleach is similar to the current method (direct smear 
microscopy) with an exception that bleach has to be added to specimen and allow it to 
sediment for 45minutes. It does not require special expertise and could be implemented 
throughout the country in peripheral health facilities. Furthermore, the method has an 
advantage of same day results for patients. This could reduce patient costs for transport 
because of few or reduced visits to the health facilities. Patients could have same day 
results and, once found with smear positive TB, could start treatment the same day 
instead of waiting for three to four days, and in some cases even one week. 
 
Bleach concentration techniques could potentially help reduce dropout rates which 
account for 15% in Malawi (Reid and Shah 2009).  Such dropouts’ occur between the 
diagnostic pathway that is between time of submitting sputum for examination and 
collection of results. Perhaps costs involved in care seeking pathways also contribute to 
such a high dropout rate (Kemp et al. 2007). Reducing the diagnostic pathway would 
ensure all patients get results in time and put on treatment within shortest possible time. 
Bleach centrifugation technique is more effective than natural sedimentation. However, 
country wide implementation would be capital intensive and would also increase 
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maintenance costs for most health facilities. Besides that less skilled workers may not be 
able to carry out the tests which will restrict usage in most rural health centres as such 
implementing this method may not be realistic in Malawi. The need for electricity makes 
it also difficult to implement centrifugation technique. Alternatively, bleach 
centrifugation could be used in main health facilities such as central hospitals and district 
hospital where there is much more workload and usually have well trained staff. 
However, the obstacle with implementing different strategies would be public response. 
People could tend to discredit rural health facilities if they know that more effective 
diagnosis in offered in main hospitals and this may even increase workload in central and 
district health facilities as such universal implementation of tuberculosis diagnostic 
technique would be the most ideal situation. 
 
6.3 Conclusion 
 
Natural sedimentation is the most cost effective method of analyzing sputum. The method 
can potentially save about 41% of TB diagnostic costs. These saved resources could be 
redirected to other interventions. Natural sedimentation technique is the most realistic 
method of analyzing sputum for tuberculosis diagnosis in Malawi that can improve 
pulmonary tuberculosis case finding. Its intrinsic feature of rendering specimen less 
infectious and easy to use makes it suitable for use in peripheral health facilities. 
 
Centrifugation is more cost effective than direct smear microscopy. The method is highly 
effective, and could also be an alternative to direct smear microscopy. However, 
implementation faces a lot of challenges as such it may not be realistic to implement in 
the Malawi health sector. Direct smear microscopy was the least cost effective method 
but also the most effective in terms of number of smear positive cases detected. 
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APPENDICES 
 
APPENDIX A: PARTICIPANT CONSENT FORM 
 
Consent form for participating in the study: A cost-effectiveness analysis of different 
ways of analyzing sputum for tuberculosis diagnosis: direct smear microscopy, natural 
sedimentation and centrifugation 
 
What is the purpose of the study? 
My name is……………….. I work for Research for Equity and Community Health 
(REACH) Trust. We are carrying out a study aimed to assess the cost effectiveness of 
different techniques of analysing sputum for pulmonary tuberculosis, namely direct 
smear, bleach natural sedimentation and bleach centrifugation. This will involve asking 
for information from management, laboratory technicians and officers from central 
medical stores. The study will collect the cost and effectiveness data (e.g. costs for 
diagnostic test, laboratory, transport, building, equipment, staff time and overheads).  
 
What are the possible benefits of participating? 
There will be no immediate benefits to you. However the information we obtain from this 
study will help policy makers and healthcare providers’ in resource allocation decisions 
in the public sector. The information you provide will play an important role in 
determining costs involved in diagnosis of tuberculosis. 
 
What are the possible drawbacks or discomforts in participating? 
The study poses no risk, pain, physical hazards or discomfort to any participant. The 
study will use financial records and other information on materials used in diagnostic 
tests for tuberculosis. 
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Do I have to participate? 
Your participation in this study is voluntary.  Should you agree to participate you are 
required to sign this form.  You are free to withdraw from the study at any stage and this 
will in no way affect your job. 
 
Will the information be treated confidentially? 
Yes, should you agree to participate in the study, all information collected for this study 
will be kept strictly confidential.  Individual responses or any other recorded information 
you provide will never be made public, and no information which could identify you will 
ever be released. 
 
Contact details 
If you have any questions about this interview contact…Mafayo Phiri… 
Tel…002659051514/ 0027788797400..Fax: 002651751247 or e-
mail…ciscophiri@yahoo.com… 
 
I,……………………………. (Name of respondent in block letters) have read and 
understood all the information given to me about my participation in this study and I was 
given the opportunity to discuss it and ask questions.  I volunteer to take part in this 
study.  I have received a copy of this consent form. 
 
_____________________            _____________ 
Signature of respondent  Date 
Interviewer/ fieldworker:  I have: 
 
Explained the nature and purpose of the study  
to the respondent 
N Y 
Handed over a copy of the consent form N Y 
 
______________________________________     ______________ 
Signature of the interviewer/fieldworker  Date 
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APPENDIX B: LETTER OF REQUEST TO COLLECT DATA AT HEALTH 
FACILITY IN MALAWI 
 
Date: …………………………………. 
Address: REACH Trust, P.O. Box 1597, Lilongwe. 
 
Dear Sir/Madam 
 
RE: Request to conduct a study Bwaila Hospital/ Malawi Liverpool Welcome Trust 
(MLW) 
 
I am Mafayo Phiri, a student at University of Cape Town (UCT), South Africa, currently 
doing a masters  degree program in Public Health specialising in Health Economics. I 
would like to undertake a study at Bwaila hospital. The study aim is to assess the cost 
effectiveness of different techniques of analysing sputum. This will involve asking for 
information from management and laboratory technicians. The study will collect cost and 
outcome data (e.g. costs for diagnostic test, laboratory, transport, building, equipment, 
staff time and overheads).  
 
It is hoped that results from this study will help in prioritization of resource use. 
 
Ethical approval has already been sought from the University of Cape Town Ethics 
Committee, National Health Research Ethics Committee in Malawi. Issues concerning 
consent and full confidentiality will be strictly adhered to at all times. A favourable 
approval to carry out this study would be appreciated. 
 
Thanks for your anticipated cooperation. 
Yours faithfully, 
Mafayo Phiri 
Principal investigator 
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APPENDIX C: COST SHEET 
 
Cost effectiveness analysis of ways of analyzing sputum for TB diagnosis; smear 
microscopy, natural sedimentation and Centrifugation. 
 
A. PERSONNEL 
 
 
 
 
Support Staff; 
 
 
B. OFFICE AND LABORATORY SPACE 
 
PERSONNEL     
  
  
    
 Laboratory 
Staff   Annual Cost     
Type of staff 
working on 
TB  
Number of Hrs 
on TB 
diagnosis 2006 2007 2008 
Proportion of 
time spent on 
average working 
on TB 
Total annual Cost 
on TB diagnosis 
(E.g. Lab 
Technicians 
and laboratory 
Managers)            
              
              
              
Total Annual 
Cost of 
Support Staff             
Support Staff     
  
  
    
    Annual Cost     
Type of staff 
working on TB  
Number 
of Hrs on 
TB 2006 2007 2008 
Proportion of 
time spent on 
Average 
working on 
TB 
Total annual Cost on TB 
diagnosis 
(Eg.Administration 
Cleaners)            
              
              
              
              
Total Annual Cost 
of Support Staff             
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Building Costs     
      
Space used (Square Metres) Cost of building space used Annualised Cost 
Laboratory     
Office     
Total     
  
 
 
C. OPERATING COSTS 
 
Operating and maintenance costs       
  2006 2007 2008 
Water       
Electricity       
Telephone       
 Microscope       
Biosafety Cabinet    
Autoclaving waste    
 Centrifuge       
 
 
 
D. EQUIPMENT 
 
Laboratory Equipment     
      
Equipment Purchasing cost Annualised Cost 
Furniture     
Centrifuge     
Microscope     
Biosafety Cabinets…     
Autoclaving waste     
……….     
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E. DIAGNOSTIC MATERIAL USAGE 
 
 
Material Usage     
  Quantity used Amount used per test 
A. Smear Microscopy     
Calibrated loop     
30ml Universal Container     
Daimond marker     
Storage boxes     
Amplicator sticks     
Slides     
Preparation agents     
Carbol fuschin stain     
Methylene blue stain     
Acid alcohol     
 
 
 
 
 
 Material Usage     
   Quantity used Amount used per test 
B. Natural Sedimentation     
Calibrated loop     
30ml Universal Container     
Daimond marker     
Storage boxes     
Amplicator sticks     
Slides     
Preparation agents     
Carbol fuschin stain     
Methylene blue stain     
Acid alcohol     
Bleach     
Pipettes     
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 Materials used 
   Quantity used  Amount used per test 
C. Centrifugation     
Calibrated loop     
30ml Universal Container     
Diamond marker     
Storage boxes     
Amplicator sticks     
Slides     
Preparation agents     
Carbol fuschin stain     
Methylene blue stain     
Acid alcohol     
LJ slope with pyruvate     
LJ slope non pyruvate     
Filter papers     
Virkon (disinfetctant)     
Pipettes     
Phosphate buffered saline     
Sodium hydroxide     
 
 
 
F. DIAGNOSTIC TIME 
 
Time Spent on Sputum 
tests     
      
Method 
Number of specimen analyzed per 
week 
Number of hours spent per 
week 
Smear microscopy     
Natural Sedimentation     
Centrifugation     
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G. OVERAL COSTS 
 
 
Time spent 
People 
involved 
Salary 
paid 
by 
Number 
of 
working 
days in 
2006 
Number 
of 
working 
days in 
2007 
Number 
of 
working 
days in 
2008 
Days 
allocated 
to TB 
Diagnosis 
2006 
Days 
allocated 
to TB 
diagnosis 
2007 
Days 
Allocated 
to Tb 
Diagnosis 
2008 
        
        
        
        
        
        
        
        
 
1. A working day is assumed to have 8 hours 
2. Number of working days excludes public holidays and weekends 
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 APPENDIX D: COSTING SHEET QUESTIONNAIRE 
 
Name of Facility: 
 
District: 
 
Respondent: 
 
Interviewer: 
 
Informed Consent: 
 
My name is……………….. I work for Research for Equity and Community Health (REACH) Trust. We are 
carrying out a study aimed to assess the cost effectiveness of different techniques of analysing sputum for 
pulmonary tuberculosis, namely direct smear, bleach natural sedimentation and bleach centrifugation. I will 
be asking you for information on amount of materials used in the study and their costs (e.g. costs for 
diagnostic test, laboratory, transport, building, equipment, staff time and overheads).  
 
Your participation in this study is voluntary.  Should you agree to participate you are required to sign a 
consent form which is on a separate sheet.  You are free to withdraw from the study at any stage and this 
will in no way affect your job. 
_____________________            _____________ 
Signature of respondent  Date 
Interviewer/ fieldworker:  I have: 
Explained the nature and purpose of the study  
to the respondent 
N Y 
Handed over a copy of the consent form N Y 
______________________________________     ______________ 
Signature of the interviewer/fieldworker  Date 
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Recurrent Costs 
 
1. In this section I would like to know about the staff working on each method of analyzing sputum, 
the time they dedicate to their tasks and their remuneration packages.(List of laboratory and Support 
Staff involved) 
(To ask staff)  
 
  Q1.1 Q1.2 Q1.3 Q1.4 Q1.5 
Laboratory Staff (lab 
technicians, managers) 
Who are the 
people 
involved in TB 
Diagnosis 
using smear 
microscopy in 
this facility? 
What is 
their role in 
this 
procedure? 
How many 
hours per 
week does 
(name) 
dedicate to 
this 
procedure 
How many 
hours per 
week does 
(name) work 
at this facility 
What is the 
total annual 
Salary that 
(name) 
Receives 
      
      
      
Support Staff (e.g. 
administration, cleaners) 
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 Q2.1 Q2.2 Q2.3 Q2.4 Q2.5 
Laboratory Staff 
(lab technicians, 
managers) 
Who are the 
people involved in 
TB Diagnosis 
using Natural 
Sedimentation in 
this facility? 
What is their 
role in this 
procedure? 
How many 
hours per 
week does 
(name) 
dedicate 
How many 
hours per 
week does 
(name) work 
at this facility 
What is the 
total annual 
Salary that 
(name) 
Receive 
      
      
Support Staff 
(e.g. 
administration, 
cleaners) 
     
      
      
 
 
 
 
 Q3.1 Q3.2 Q3.3 Q3.4 Q3.5 
Laboratory Staff 
(lab technicians, 
managers) 
Who are the 
people involved 
in TB 
Diagnosis using 
Centrifugation 
in this facility? 
What is their 
role in this 
procedure? 
How many 
hours per week 
does (name) 
dedicate 
How many 
hours per 
week does 
(name) 
work at this 
facility 
What is the 
total annual 
Salary that 
(name) 
Receive 
      
      
Support Staff 
(e.g. 
administration, 
cleaners) 
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Usage and Cost of Diagnostic Materials 
 
4. In this section I will ask questions on quantities of diagnostic materials that were used for each of 
the methods. Below is the list of the materials used. (Cost of Materials to check on procurement records or 
central medical stores) 
 
4.1 Smear Microscopy  
 
Materials Per week Per month Total used 
 Quantity Cost Quantity Cost Quantity Cost 
Calibrated 
loop 
      
30ml 
universal 
container 
      
Diamond 
marker 
      
Storage 
boxes 
      
Applicator 
Sticks 
      
Slides       
Preparation 
agents 
      
Carbol 
fuschin stain 
      
Methylene 
blue stain 
      
Acid alcohol       
       
       
 
4.2 Natural Sedimentation 
Materials Per week Per month Total used 
 Quantity Cost Quantity Cost Quantity Cost 
Calibrated 
loop 
      
30ml 
universal 
container 
      
Diamond 
marker 
      
Storage 
boxes 
      
Applicator 
Sticks 
      
Slides       
Preparation 
agents 
      
Carbol 
fuschin stain 
      
Methylene 
blue stain 
      
Bleach       
Pipettes       
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4.3 Centrifugation 
Materials Per week Per month Total used 
 Quantity Cost Quantity Cost Quantity Cost 
Calibrated loop       
30ml universal 
container 
      
Diamond 
marker 
      
Storage boxes       
Applicator 
Sticks 
      
Slides       
Preparation 
agents 
      
Carbol fuschin 
stain 
      
Methylene blue 
stain 
      
Acid alcohol       
LJ slope with 
pyruvate 
      
Lj slope non 
pyruvate 
      
Filter papers       
Virkon 
(disinfectants) 
      
Pipettes       
Phosphate 
buffered saline 
      
Sodium 
hydroxide 
      
 
 
 
5.0 Time for carrying out tests (laboratory technicians to respond verified through records) 
 
This section has questions about time you take to analyze sputum for each of the methods used from the 
time specimen is taken to the time results are reported to the patient. 
 
Time spent on Sputum tests 
Method Number of 
Specimen 
Analyzed per 
week 
Number of hours 
spent per week 
Number of 
specimen 
analyzed per 
month 
Number of 
hours spent per 
month 
Smear Microscopy     
Natural 
Sedimentation 
    
Centrifugation     
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6.0 Capital Costs  
(To take actual measurements of laboratory and office space, Cost of building sourced from Contractors) 
 
Building costs Space Used (square 
meterage) 
Cost of building space 
used 
Annualized cost 
Laboratory Space    
Office space    
    
 
 
6.1. Laboratory Equipment (Physical observation of equipments used costs to check through procurement 
records) 
 
6.2. Cost of the following equipment used for analyzing sputum. (To verify cost with facility records) 
 
Laboratory Equipment   
 Purchasing Cost Annualized Costs 
Centrifuge   
Microscope   
Autoclaving waste   
Biosafety Cabinet   
Slide dryer   
 
 
 
7.0. Operating and Maintenance costs (record reviews) 
 
I would like to know the costs incurred for overheads during the entire period of the study; 
 
Overheads     
 Costs in 2006 Costs in 2007 Costs in 2008 Total Costs 
Water     
Electricity     
Telephone     
Other utilities     
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